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This dissertation focuses on three projects. In Chapter 1, we derive and imple-
ment the compact implicit integration factor method for numerically solving partial
differential equations. In Chapters 2 and 3, we generalize and analyze a mathematical
model for the nonlinear growth kinetics of breast cancer stem cells. And in Chap-
ter 4, we develop a novel mathematical model for the HER2 signaling pathway to
understand and predict breast cancer treatment.
Due to the high order spatial derivatives and stiff reactions, severe temporal sta-
bility constraints on the time step are generally required when developing numeri-
cal methods for solving high order partial differential equations. Implicit integration
method (IIF) method along with its compact form (cIIF), which treats spatial deriva-
tives exactly and reaction terms implicitly, provides excellent stability properties with
good efficiency by decoupling the treatment of reaction and spatial derivatives. One
major challenge for IIF is storage and calculation of the potential dense exponen-
tial matrices of the sparse discretization matrices resulted from the linear differential
operators. The compact representation for IIF (cIIF) was introduced to save the
computational cost and storage for this purpose. Another challenge is finding the
matrix of high order space discretization, especially near the boundaries. In Chapter
1, we extend IIF method to high order discretization for spatial derivatives through
an example of reaction diffusion equation with fourth order accuracy, while the com-
putational cost and storage are similar to the general second order cIIF method. The
method can also be efficiently applied to deal with other types of partial differential
equations with both homogeneous and inhomogeneous boundary conditions. Direct
iii
numerical simulations demonstrate the efficiency and accuracy of the approach.
Cancer stem cells are responsible for tumor survival and resurgence and are thus
essential in developing novel therapeutic strategies against cancer. Mathematical
models can help understand cancer stem and differentiated cell interaction in tumor
growth, thus having the potential to aid in designing experiments to develop novel
therapeutic strategies against cancer. In Chapter 2, by using theory of functional
and ordinary differential equations, we study the existence and stability of non-linear
growth kinetics of breast cancer stem cells. First we provide a sufficient condition for
the existence and uniqueness of the solution for non-linear growth kinetics of breast
cancer stem cells. Then we study the uniform asymptotic stability of the zero solution.
By using linearization techniques, we also provide a criteria for uniform asymptotic
stability of a non-trivial steady state solution with and without time delays. We
present a theorem from complex analysis that gives certain conditions which allow
for this criteria to be satisfied. Next we apply these theorems to a special case of
the system of functional differential equations that has been used to model non-linear
growth kinetics of breast cancer stem cells. The theoretical results are further justified
by numerical testing examples. Consistent with the theories, our numerical examples
show that the time delays can disrupt the stability. All the results can be easily
extended to study more general cell lineage models.
Solid tumors are heterogeneous in composition. Cancer stem cells (CSCs) are a
highly tumorigenic cell type found in developmentally diverse tumors that are be-
lieved to be resistant to standard chemotherapeutic drugs and responsible for tumor
recurrence. Thus understanding the tumor growth kinetics is critical for developing
novel strategies for cancer treatment. In Chapter 3, the moment stability of nonlin-
ear stochastic systems of breast cancer stem cells with time-delays is investigated.
First, based on the technique of the variation- of-constants formula, we obtain the
second order moment equations for the nonlinear stochastic systems of breast cancer
iv
stem cells with time-delays. By the comparison principle along with the established
moment equations, we can get the comparative systems of the nonlinear stochastic
systems of breast cancer stem cells with time-delays. Then moment stability theo-
rems are established for the systems with the stability properties for the comparative
systems. Based on the linear matrix inequality (LMI) technique, we next obtain a
criteria for the exponential stability in mean square of the nonlinear stochastic sys-
tems for the dynamics of breast cancer stem cells with time-delays. Finally, some
numerical examples are presented to illustrate the efficiency of the results.
Over-expression of human epidermal growth factor receptor 2 (HER2) plays a role
in regulation of cancer stem cell (CSC) population in breast cancer. Current cancer
therapy includes drugs that block HER2, however, patients can develop anti-HER2
drug resistance. Downstream of HER2 is nuclear factor κB (NFκB). The aberrant
regulation of NFκB leads to cancer growth, which makes it a promising target for
cancer therapy, especially for those who have developed resistance to anti-HER2
treatment. In Chapter 4 we develop a novel mathematical model that represents
the dynamics of the HER2 signaling pathway. By integrating experimental data
with model simulations, we discover that interleukin-1 (IL1), which is downstream of
HER2, is responsible for NFκB activation. We perform global sensitivity analysis on
the model to identify key reactions. Our modeling effort shows that IL1 is critical
in NFκB regulation, especially in the absence of HER2, making it a potential target
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Chapter 1
High order compact integration factor method
for systems with inhomogeneous boundary
conditions
1.1 Introduction
Let Ω be an open rectangular domain in Rd and a final time T > 0. In this paper,
we consider solving a system of reaction-diffusion equation:
∂u
∂t = −D∆u+ f(u), x ∈ Ω, t ∈ (0, T ),
u|t=0 = u0, x ∈ Ω,
(1.1)
where D > 0 is the diffusion coefficient. Different boundary conditions such as the
Dirichlet boundary condition, periodic boundary condition or Neumann boundary
condition will all be studied in this paper. Due to severe time step constraints, one of
the numerical difficulties to handle such equations is to efficiently solve the diffusion
term ∆u coupled with the stiff nonlinear reaction term f(u). In general, the time step
relies heavily on the stiffness of reactions and treatment of the high order derivatives.
Integration factor (IF) or exponential differencing time (ETD) methods are popular
methods for temporal partial differential equations (PDEs) [1–7].
To efficiently store and compute the exponential matrices in IIF for two and three
dimensional systems in Cartesian coordinates with regular meshes, a class of compact
implicit integration factor (cIIF) method [8] was introduced that has the same stabil-
ity properties as the original IIF [9], but with significant improvement on storage and
1
computational savings for high spatial dimensions. In order to efficiently handle the
complex domains with circular or spherical symmetry, cIIF methods were generalized
to curvilinear coordinates through examples of polar and spherical coordinates [10].
One can also apply cIIF to stiff reactions and diffusions while using other special-
ized hyperbolic solvers (e.g WENO methods [11, 12]) for convection terms to solve
reaction-diffusion-convection equations efficiently [13].
The compact form of integration factor method was often very hard to be di-
rectly applied to deal with problems involving cross derivatives. Recently in [14], the
compact integration factor (cIF) method was applied to solve a family of semilin-
ear fourth-order parabolic equations, in which the bi-Laplace operator is explicitly
handled. The proposed method can also deal with not only stiff nonlinear reaction
terms but also various types of homogeneous or inhomogeneous boundary conditions,
while how to deal with inhomogeneous boundary conditions with cIF was not ad-
dressed before. Meanwhile, the IF method was designed and tested primarily for
reaction-diffusion equations in previous studies. More recently in [15], cIF method
was extended to solve the dissipative hydrodynamic equation system for incompress-
ible fluid mixture flows with more complex mathematical structures. The IF strategy
is applied after the system is discretized in space into a large differential and algebraic
equation (DAE) system, which respects the total energy dissipation. The computa-
tional cost can be dramatically reduced through the use of discrete Fourier transform
(DFT) by taking advantage of the circular structure of discretized matrices. The
proposed approach has exhibited great numerical stability and energy dissipation
property.
One challenge for integration factor (IF) method is to find the matrix of high
order space discretization, especially near the boundaries, while all previous stud-
ies are mainly focusing on second order discretization in space. In this paper, we
generalize IF methods for efficiently handling reaction-diffusion systems with high
2
order accuracy for various inhomogeneous boundary conditions. In this approach, we
use standard fourth order central finite differences for spatial discretization coupled
with compact implicit integration factor methods for time discretization. In two and
three dimensional system, the discretized matrices arising from a compact represen-
tation of diffusion operator need to be diagonalized once and pre-calculated before
each time step iteration. This new approach has similar stability properties as the
general second order cIIF along with a similar computational cost. Thus the method
is particularly suitable for high order partial differential equations in high dimen-
sional systems with high order accuracy for both homogeneous and inhomogeneous
boundary conditions.
To study the accuracy and efficiency, we first derive and implement the IF method
to efficiently solve reaction-diffusion systems with inhomogeneous Neumann bound-
ary conditions. Such approach can be similarly extended to all other inhomogeneous
boundary conditions. The direct numerical simulations exhibit the excellent perfor-
mance of the proposed approach through extensive numerical benchmark tests with
the linear and nonlinear equations. The rest of the chapter is organized as follows.
The derivation of the fourth order spatial discretization is in Section 1.2. The gener-
alization of IF methods for reaction-diffusion systems for inhomogeneous Neumann
boundary conditions are presented in Section 1.3, and numerical tests with linear and
nonlinear cases are shown in Section 1.4. Finally a brief conclusion is drawn [16].
1.2 Derivation of High Order Discretization
1.2.1 Fourth order central finite difference discretization on the second
derivative






+ F(u), a < x < b. (1.2)
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After spatial discreization, this equation can be written as
dU
dt = AU + F(U), (1.3)
where U ∈ R(N+1)×1, A ∈ R(N+1)×(N+1), and F defined as above. We will derive
a fourth order central finite difference discretization on the second derivative, which
will tell us the form of A.
Let (a, b) be an interval and a = x0 < x1 < ... < xN = b be a partition with step
size h = (b− a)/N . Then we have the following Taylor series expansions.

































































































































Denote ui = u(xi), ui+1 = u(xi + h), etc. Rearranging these equations and then
adding (1.6) to (1.7) yields






Similarly, from (1.4) and (1.5) we have






Subtracting 16·(1.13) from (1.12) yields
ui+2 − 16ui+1 + 30ui − 16ui−1 + ui−2 = −12u′′i h2 +O(h6). (1.14)
By rearranging this equation we get a fourth order approximation for the second
derivative:
u′′i ≈
−ui+2 + 16ui+1 − 30ui + 16ui−1 − ui−2
12h2 . (1.15)
Another way to get the same fourth order approximation for the second derivative
is to increase the step size in (1.13) from h to 2h.











Again subtracting 16·(1.13) from (1.16) yields
ui+2 − 16ui+1 + 30ui − 16ui−1 + ui−2 = −12u′′i h2 +O(h6), (1.17)
from which we get
u′′i ≈
−ui+2 + 16ui+1 − 30ui + 16ui−1 − ui−2
12h2 . (1.18)
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This tells us the the form of A, excluding the first and last two rows. They will be
determined by the boundary condition. Let Ã ∈ R(N−3)×(N+1) denote the interior
rows of A. Then
Ã = D12h2 ×

−1 16 −30 16 −1
−1 16 −30 16 −1
. . . . . . . . . . . . . . .





Note that for i = 0, 1, the scheme (1.15) contains the points u−1 and u−2, and for
i = N − 1, N , it contains the points uN+1 and uN+2. In this section we will derive a
fourth order approximation for these points again from the Taylor series.
Neumann Boundary Condition
Consider the nonhomogeneous Neumann boundary condition
∂u
∂x
(a) = α, ∂u
∂x
(b) = β. (1.20)
Subtracting (1.5) from (1.4) and (1.7) from (1.6) yields








Subtracting (1.22) from 8·(1.21) and rearranging yields a fourth order approximation
for the first derivative:
u′i ≈
−ui+2 + 8ui+1 − 8ui−1 + ui−2
12h . (1.23)
We will derive another fourth order approximation for the first derivative, this
time by including the points ui+3 and ui+4 instead of ui−2.
6
From the operations 4 · (1.8)− 9 · (1.6) and (1.10)− 4 · (1.6), we get




ui+4 − 4ui+2 = −3ui − 4u′ih+
16u′′′i
3 h
3 + 8u(4)i h4 +O(h5). (1.25)
15 · (1.25)− 16 · (1.24) yields
15ui+4 − 64ui+3 + 84ui+2 − 35ui = 36u′ih− 16u′′′i h3 +O(h5). (1.26)
Now, (1.26) + 48 · (1.21) yields
15ui+4 − 64ui+3 + 84ui+2 + 48ui+1 − 35ui − 48ui−1 = 132u′ih+O(h5), (1.27)
from which we get another fourth order approximation for the first derivative:
u′i ≈
15ui+4 − 64ui+3 + 84ui+2 + 48ui+1 − 35ui − 48ui−1
132h . (1.28)
From (1.20) we have the boundary value u′0 = α. Then for i = 0, (1.28) becomes
15u4 − 64u3 + 84u2 + 48u1 − 35u0 − 48u−1 = 132hα, (1.29)
from which we get
u−1 =





−u2 + 8u1 − 8u−1 + u−2 = 12hα, (1.31)
from which we get
u−2 = u2 − 8u1 + 8u−1 + 12hα
= u2 − 8u1 + 8
(






= 15u4 − 64u3 + 90u2 − 35u06 − 10hα. (1.32)
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For the homogeneous Neumann boundary condition, we get the same result, but
without the α term.
We will derive another fourth order approximation for the first derivative, this
time by including the points ui−3 and ui−4 instead of ui+2.
From the operations 4 · (1.9)− 9 · (1.7) and (1.11)− 4 · (1.7), we get




ui−4 − 4ui−2 = −3ui + 4u′ih−
16u′′′i
3 h
3 + 8u(4)i h4 +O(h5). (1.35)
15 · (1.35)− 16 · (1.34) yields
15ui−4 − 64ui−3 + 84ui−2 − 35ui = −36u′ih+ 16u′′′i h3 +O(h5). (1.36)
Now, (1.36)− 48 · (1.21) yields
15ui−4 − 64ui−3 + 84ui−2 − 48ui+1 − 35ui + 48ui−1 = −132u′ih+O(h5), (1.37)
from which we get another fourth order approximation for the first derivative:
u′i ≈
−15ui−4 + 64ui−3 − 84ui−2 + 48ui+1 + 35ui − 48ui−1
132h . (1.38)
From (1.20) we have the boundary value u′N = β. Then for i = N , (1.38) becomes
−15uN−4 + 64uN−3 − 84uN−2 + 48uN+1 + 35uN − 48uN−1 = 132hβ, (1.39)
from which we get
uN+1 =






−uN+2 + 8uN+1 − 8uN−1 + uN−2 = 12hβ, (1.41)
from which we get
uN+2 = uN−2 − 8uN−1 + 8uN+1 − 12hβ
= uN−2 − 8uN−1 + 8
(






= 15uN−4 − 64uN−3 + 90uN−2 − 35uN6 + 10hβ. (1.42)
Substituting (1.40) and (1.42) into (1.15) for i = N − 1, N yields
uN−1 =
803




















For the homogeneous Neumann boundary condition, we get the same result, but
without the β term.
The α and β terms in (1.33) and (1.43) can be moved to the reaction term in
(1.3). Incorporating these equations in Ã yields
A = D12h2 ×














−1 16 −30 16 −1
−1 16 −30 16 −1
. . . . . . . . . . . . . . .
−1 16 −30 16 −1




















Consider the inhomogeneous Dirchlet boundary condition
u(a) = α, u(b) = β. (1.45)
Since we know u0 and uN , we do not need rows 0 and N in A. We still need to rewrite
the expressions for u1 and uN−1, though, since they involve the terms u−1 and uN+1,
respectively.
Recall the fourth order approximations derived for the first derivative of u in the
previous section
u′i ≈
−ui+2 + 8ui+1 − 8ui−1 + ui−2
12h ,
u′i ≈
15ui+4 − 64ui+3 + 84ui+2 + 48ui+1 − 35ui − 48ui−1
132h ,
u′i ≈
−15ui−4 + 64ui−3 − 84ui−2 + 48ui+1 + 35ui − 48ui−1
132h .
Subtracting the top equation from the middle equation yields
0 = 15ui+4 − 64ui+3 + 95ui+2 − 40ui+1 − 35ui + 40ui−1 − 11ui−2 (1.46)
From taking i = 1 and rearranging, we get
u−1 =
1
11(15u5 − 64u4 + 95u3 − 40u2 − 35u1 + 40u0). (1.47)
Subtracting the bottom equation from the top equation yields
0 = −11ui+2 + 40ui+1 − 35ui − 40ui−1 + 95ui−2 − 64ui−3 + 15ui−4 (1.48)
From taking i = N − 1 and rearranging, we get
uN+1 =
1
11(40uN − 35uN−1 − 40uN−2 + 95uN−3 − 64uN−4 + 15uN−5) (1.49)
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For the homogeneous Dirchlet boundary condition, we get the same result, but with-
out the α and β terms.
The α and β terms in (1.50) can be moved to the reaction term in (1.3). Incor-
porating these equations in Ã yields











16 −30 16 −1 0
−1 16 −30 16 −1
−1 16 −30 16 −1
. . . . . . . . . . . . . . .
−1 16 −30 16 −1
−1 16 −30 16 −1















1.2.3 Dealing with the Extra Term from the inhomogeneous Neumann
Boundary Condition
With the inhomogeneous Neumann boundary condition, we get extra terms for u0,

















Likewise, with the inhomogeneous Dirchlet boundary condition, we get extra terms



















dt = AU + F(U) + G. (1.54)
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1.3 High Order integration factor (IF) method with inhomogeneous
Boundary Conditions
1.3.1 One-Dimension






+ F(u), x ∈ Ω, t ∈ [0, T ]
∂u
∂x
(t, x) = g(t, x) x ∈ ∂Ω, t ∈ [0, T ]
, (1.55)
where Ω = [a, b]. We first discretize the spatial domain by the mesh: xi = a + i× h
where h = (b − a)/N and 0 ≤ i ≤ N . Using the fourth order central difference
discretization on the diffusion, we obtain a system of nonlinear ODEs
dui
dt = D
(−ui+2 + 16ui+1 − 30ui + 16ui−1 − ui−2
12h2
)
+ F(ui) + G. (1.56)
Next we define vectors U and G and a matrix A by



















A = D12h2 ×














−1 16 −30 16 −1
−1 16 −30 16 −1
. . . . . . . . . . . . . . .

















In terms of this vector and matrix, the semi-discretized form (1.56) becomes
dU
dt = AU + F(U) + G. (1.60)
To apply the integration factor technique to the compact discretization form
(1.60), we multiply (1.60) by exponential matrix e−At from the left to obtain
d(e−AtU)
dt = e
−AtF(U) + e−AtG. (1.61)
Integration of (1.61) over one time step from tn to tn+1 ≡ tn + ∆t, where ∆t is
the time step, leads to
Un+1 = eA∆tUn + eA∆t
(∫ ∆t
0







As discussed in [14, 17], to evaluate the integral resulted from the inhomogeneous
boundary terms ∫ ∆t
0
e−AτG(tn + τ)dτ,
we need to be careful since G(tn+τ) contains entries which decay with highly different
speeds along the time, and it involves the factors of 1/h2 which could quickly am-
plify errors arising from the time discretization, which would cause severe numerical
14
instability. To overcome this difficulty, we will apply an elegant approach proposed
in [14, 17], which will be described with details in the following.
To construct a scheme of rth order truncation error, we approximate the inte-
grands in (1.62),
H1(τ) ≡ e−AτF(U(tn + τ)), H2(τ) ≡ G(tn + τ),
using a (r− 1)th order Lagrange polynomial at a set of interpolation points tn+1, tn,













(k − j)∆t . (1.63)
In terms of P1(τ) and P2(τ) (1.62) takes the form,









So the new rth order implicit schemes are










where α1, α0, α−1, . . . , α−r+2 and β1, β0, β−1, . . . , β−r+2 are coefficients calculated



















(k − j)∆tdτ, −1 ≤ j ≤ r − 2. (1.66)
In Table (1.1), the values of the coefficients α−j for schemes of order up to four are
listed.
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Table 1.1: Values of α−j in (1.66) up to order three.
r α1 α0 α−1 α−2
































k ≥ 1. (1.67)
Then the coefficients β−j for schemes of order up to four are listed in Table (1.2).
Table 1.2: Values of β−j in (1.66) up to order three where ξk is defined in (1.67)
r β1 β0 β−1 β−2
1 ξ0 0 0 0
2 ξ1 −ξ1 + ξ0 0 0
3 12ξ2 +
1






















Remark 1: Even though the integration factor method are derived in the context
of inhomogeneous Neumann boundary conditions, it can be similarly extended to
inhomogeneous Dirichlet boundary conditions.
1.3.2 Two-Dimensions
Now we consider a two-dimensional reaction-diffusion equation with with inhomoge-







) + F(u), (x, y) ∈ Ω, t ∈ [0, T ]
∂u
∂x
(t, x, y) = g1(t, x, y) (x, y) ∈ ∂Ω, t ∈ [0, T ]
∂u
∂y
(t, x, y) = g2(t, x, y) (x, y) ∈ ∂Ω, t ∈ [0, T ]
, (1.68)
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where Ω = [a, b]× [c, d]. We first discretize the spatial domain by the mesh: (xi, yj) =
(a+ i× hx, c+ j × hy) where hx = (b− a)/Nx, hy = (d− c)/Ny, and 0 ≤ i ≤ Nx and
0 ≤ j ≤ Nj. Using the fourth order central difference discretization on the diffusion,




−ui+2,j + 16ui+1,j − 30ui,j + 16ui−1,j − ui−2,j
12h2x
(1.69)
+ −ui,j+2 + 16ui,j+1 − 30ui,j + 16ui,j−1 − ui,j−212h2y
)
+ F(ui,j) + G1 + G2.
Next we define matrices U, G1, G2, A, and B by
U =

u0,0 u0,1 · · · u0,Ny u0,Ny
u1,0 u1,1 · · · u1,Ny u1,Ny
... ... . . . ... ...

















48 · · ·
11g1(t,x0,yN )
48
0 0 · · · 0
... ... . . . ...
0 0 · · · 0
−11g1(t,xN ,y0)48 −
11g1(t,xN ,y1)



















48 0 · · ·
−17g1(t,x1,y0)6
11g1(t,x1,y0)
48 0 · · ·
... ... ... . . .
−17g1(t,xN ,y0)6
11g1(t,xN ,y0)
48 0 · · ·
(1.72)
17
· · · 0 −11g1(t,x0,yN )48
17g1(t,x0,yN )
6
· · · 0 −11g1(t,x1,yN )48
17g1(t,x1,yN )
6
. . . ... ... ...






















−1 16 −30 16 −1
−1 16 −30 16 −1
. . . . . . . . . . . . . . .

























32 −31 16 −1












. . . 16 13 −
32
3
−1 . . . −30 574 12








In terms of these matrices, the semi-discretized form (1.70) becomes
dU
dt = AU + UB + F(U) + G1 + G2. (1.76)
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Since A and B can be diagonalized,
A = PADAP−1A B = PBDBP−1B .




A UPB + P−1A UPBDB
+ P−1A F(U)PB + P−1A G1PB + P−1A G2PB. (1.77)
Let
V = P−1A UPB, F̃ = P−1A FPB, G̃1 = P−1A G1PB, G̃2 = P−1A G2PB.
Then (1.77) becomes
dV
dt = DAV + VDB + F̃(PAVP
−1
B ) + G̃1 + G̃2. (1.78)
To apply the integration factor technique to the compact discretization form
(1.78), we multiply (1.78) by the exponential matrix e−DAt on the left, and e−DBt
on the right and take integration over one time step from tn to tn+1 ≡ tn + ∆t, where
∆tis the time step. It leads to
Vn+1 = eDA∆tVneDB∆t + eDA∆t
(∫ ∆t
0







e−DAτ G̃2(tn + τ)e−DBτdτ
)
eDB∆t. (1.79)
Similar to one-dimensional case, to construct a scheme of rth order truncation
error, we approximate the integrands in (1.79) using a (r − 1)th order Lagrange








G̃1(tn − j∆t)pj(τ), P3(τ) ≡
r−2∑
j=−1








(k − j)∆t . (1.81)
In terms of Pi(τ), i = 1, 2, 3, (1.79) takes the form,













Let DA = diag(da0, da1, · · · , daNx) and DB = diag(db0, db1, · · · , dbNy). Note that multi-
plication of diagonal matrices on the left and right becomes component-wise matrix
multiplication of the form
(DAGDB)i,j = dai (G)i,jdbj. (1.83)
So the second integration in (1.82) can be done component-wise. Now the new rth
order implicit schemes are












β−j ◦ G̃1(tn − j∆t) +
r−2∑
j=−1
β−j ◦ G̃2(tn − j∆t)
 eDB∆t, (1.84)
where ◦ denotes component-wise matrix multiplication and α1, α0, α−1, . . . , α−r+2




















(k − j)∆tdτ, −1 ≤ j ≤ r − 2. (1.85)
In Table (1.1), the values of the coefficients α−j for schemes of order up to three are

























k ≥ 1. (1.86)
Then the coefficients β−j for schemes of order up to three are listed in Table (1.2).
From here the solution of U can be recovered by U = PAVP−1B .
Remark 2: For the cases when A or B can not be diagonalized, the terms from
inhomogeneous boundary terms can be incorporated into the nonlinear term F . For
instance, the equation (1.76) can be written as
dU
dt = AU + UB + F̄(U). (1.87)
where F̄(U) = F(U) + G1 + G2. We can follow the same ideas for compact implicit
integration factor (cIIF) method as discussed in [8]. For instance, the second order
cIIF2 method is given by












= D∆u+ F(u), (x, y, z) ∈ Ω, t ∈ [0, T ]
∂u
∂x
(t, x, y, z) = g1(t, x, y, z) (x, y, z) ∈ ∂Ω, t ∈ [0, T ]
∂u
∂y
(t, x, y, z) = g2(t, x, y, z) (x, y, z) ∈ ∂Ω, t ∈ [0, T ]
∂u
∂z
(t, x, y, z) = g3(t, x, y, z) (x, y, z) ∈ ∂Ω, t ∈ [0, T ]
(1.88)
where Ω = [al, au]× [bl, bu]× [cl, cu]. Let Nx, Ny, Nz denote the number of spatial grid
points in x, y, z-direction, respectively, hx, hy, hz be the grid size, and ui,j,k represent
the approximate solution at the grid point (xi, yj, zk), 0 ≤ i ≤ Nx, 0 ≤ j ≤ Ny, and





−ui+2,j,k + 16ui+1,j,k − 30ui,j,k + 16ui−1,j,k − ui−2,j,k
12h2x
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+ −ui,j+2,k + 16ui,j+1,k − 30ui,j,k + 16ui,j−1,k − ui,j−2,k12h2y
+ −ui,j,k+2 + 16ui,j,k+1 − 30ui,j,k + 16ui,j,k−1 − ui,j,k−212h2z
)
+ F(ui,j,k) + Gi,j,k (1.89)
DefineAx = Dh2xA(Nx+1)×(Nx+1), Ay =
D
h2y

















−1 16 −30 16 −1
−1 16 −30 16 −1
. . . . . . . . . . . . . . .




























+ F(U) + G (1.90)






−17g1(t,x0,y0,z0)6 · · · −
17g1(t,x0,y0,zNz )
6
... . . . ...












48 · · ·
11g1(t,x0,y0,zNz )
48
... . . . ...
11g1(t,x0,yNy ,z0)












−11g1(t,xN ,y0,z0)48 · · · −
11g1(t,xN ,y0,zNz )
48
... . . . ...
−11g1(t,xN ,yNy ,z0)48 · · · −











6 · · ·
17g1(t,xN ,y0,zNz )
6
... . . . ...
17g1(t,xN ,yNy ,z0)
6 · · ·





Gi,0,k, Gi,1,k, Gi,Ny−1,k, Gi,Ny ,k, and Gi,j,0, Gi,j,1, Gi,j,Nz−1, Gi,j,Nz are similarly defined.
For i 6= 0, 1, Nx − 1, Nx, j 6= 0, 1, Ny − 1, Ny, and k 6= 0, 1, Nz − 1, Nz, Gi,j,k = 0.
The three summation terms in (1.90) are similar to the two vector-matrix mul-
tiplications in the two-dimensional case in (1.76).In addition to a left multiplication
and a right multiplication in (1.76), there is a "middle" multiplication in (1.90).
Since Aγ can be diagonalized,
Aγ = PγDγP−1γ γ = x, y, z. (1.91)








(P−1z )k,f (P−1y )j,e(P−1x )i,dud,e,f . (1.92)


























































Make the following substitutions,
V = DU, F̃ = DF , G̃ = DG.











+ F̃(D−1V) + G̃ (1.94)























Letting L(t) act on both sides of (1.94) and using (1.96), we obtain
dL(t)V
dt = L(t)F̃(D
−1V) + L(t)G̃. (1.97)
Integrating (1.97) over one time step from tn to tn+1 and using a transformation
s = tn + τ for the integration, we obtain







L(τ)G̃(tn + τ)dτ. (1.98)
Applying L(−tn+1) on both sides of (1.98) yields







L(τ)G̃(tn + τ)(τ)dτ. (1.99)
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To derive (1.99), we have used two identities:
L(0)V = V and L(−rt)L(st)V = L((s− r)t)V (1.100)
for any two scalars r and s. Both of these can be easily proved based on the definition
of L.
Similar to one and two dimensional cases, to construct a scheme of rth order
truncation error, we approximate the integrands in (1.99) using a (r − 1)th order














(k − j)∆t . (1.102)
In terms of Pi(τ), i = 1, 2, (1.99) takes the form,









So the new rth order implicit schemes are







β−j ◦ G̃(tn − j∆t)
 , (1.104)
where ◦ denotes component-wise multiplication of the three-dimensional matrices,
and α1, α0, α−1, . . . , α−r+2 andβ1, β0, β−1, . . . , β−r+2 are coefficients calculated from




















(k − j)∆tdτ, −1 ≤ j ≤ r − 2. (1.105)
In Table (1.1), the values of the coefficients α−j for schemes of order up to three are
































γ ≥ 1. (1.106)
Then the coefficients β−j for schemes of order up to three are listed in Table (1.2).








(Pz)k,f (Py)j,e(Px)i,dud,e,f . (1.107)
Remark 3: The scheme (1.104) has a form similar to the one-and two-dimensional
case. The evaluation of the nonlinear term F at tn+1 is still local and decoupled from
the global diffusion term such that a nonlinear system of the size F needs to be solved
at each spatial grid point. Such approach can also be similarly extended to systems
with any high spatial dimensions.
1.4 Numerical Examples
To study the efficacy and accuracy of the fourth order compact implicit integra-
tion factor (cIIF) method, we will implement it on the systems in two- and three-
dimensions. We test it on examples with either homogeneous or inhomogeneous
boundary conditions for both linear and nonlinear systems. In the calculation, the
exponential of the square matrix is computed using "expm" of MATLAB which uses
a scaling and squaring algorithm with a Pade approximation.
Because the matrix exponentials depend only on the spatial grid size, the time
step, and diffusion coefficient, during the entire temporal updating, they only need
to be calculated once initially for a fixed numerical resolution. The local nonlinear
systems resulting from cIIF are solved iteratively using Newton’s method.
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In all examples, the cIIF scheme is implemented with fourth order both in time
and space. It is implemented in MATLAB up to T = 1 at which the L∞ difference
between the numerical solution and the exact solution is measured. For the cases
when the exact solution is not given, we take the numerical solution with relatively
fine mesh as the "exact" solution. We set hx = hyfor the two-dimensional examples
and hx = hy = hz for the three-dimensional examples. The inhomogeneous boundary
condition algorithm has a higher requirement on the space to time step ratio, h∆t , for
stability than the homogeneous boundary condition algorithm. So we use a smaller
time step for the inhomogeneous examples. The scheme is executed on a PC laptop
with Intel Core 2 Solo processor with 4GB RAM. The error, spatial order, and code
execution time results are in Tables (1.3) and (1.4). The fourth order accuracy can
be observed for all the examples except for example 8, and we believe that the order
might be compromised since the selected time step is not sufficiently small, while the
simulation takes too long for such a three-dimensional system.
Example 1: linear problem in two-dimensions with homogeneous Neumann boundary
conditions










+ 0.1u, (x, y) ∈ Ω = {0 < x < 2π, π/2 < y < 5π/2};
∂u
∂x
(0, y, t) = ∂u
∂x
(2π, y, t) = 0;
∂u
∂y
(x, π/2, t) = ∂u
∂y
(x, 5π/2, t) = 0;
u(x, y, 0) = cos x+ sin y.
(1.108)
The exact solution of the system is
u(x, y, t) = e−0.1t(cosx+ sin y). (1.109)
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Example 2: nonlinear problem in two-dimensions with homogeneous Neumann bound-
ary conditions










+ sin u, (x, y) ∈ Ω = {0 < x < 2π, π/2 < y < 5π/2};
∂u
∂x
(0, y, t) = ∂u
∂x
(2π, y, t) = 0;
∂u
∂y
(x, π/2, t) = ∂u
∂y
(x, 5π/2, t) = 0;
u(x, y, 0) = cos x+ sin y.
(1.110)
Since we do not know the exact solution, we treat the calculated solution for a
very fine spatial mesh as the exact solution. The fine mesh is 1280 × 1280 × 640,
(Nx×Ny ×Nt). The cIIF scheme took about 12.5 hours to calculate the solution on
this fine mesh.
Example 3: linear problem in two-dimensions with homogeneous Dirichlet boundary
conditions










+ 0.1u, (x, y) ∈ Ω = {0 < x < 2π, π/2 < y < 5π/2};
u(0, y, t) = u(2π, y, t) = 0;
u(x, π/2, t) = u(x, 5π/2, t) = 0;
u(x, y, 0) = sin x cos y.
(1.111)
The exact solution of the system is
u(x, y, t) = e−0.1t sin x cos y. (1.112)
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Example 4: nonlinear problem in two-dimensions with homogeneous Dirichlet bound-
ary conditions










+ sin u, (x, y) ∈ Ω = {0 < x < 2π, π/2 < y < 5π/2};
u(0, y, t) = u(2π, y, t) = 0;
u(x, π/2, t) = u(x, 5π/2, t) = 0;
u(x, y, 0) = sin x cos y.
(1.113)
Since we do not know the exact solution, we treat the calculated solution for a
very fine spatial mesh as the exact solution. The fine mesh is 1280 × 1280 × 640,
(Nx×Ny ×Nt). The cIIF scheme took about 11.6 hours to calculate the solution on
this fine mesh.
Example 5: linear problem in two-dimensions with inhomogeneous Dirichlet boundary
conditions










+ 0.1u, (x, y) ∈ Ω = {π/2 < x < 5π/2, 0 < y < 2π};
u(π/2, y, t) = u(5π/2, y, t) = e−0.1t cos y;
u(x, 0, t) = u(x, 2π, t) = e−0.1t sin x;
u(x, y, 0) = sin x cos y.
(1.114)
The exact solution of the system is
u(x, y, t) = e−0.1t sin x cos y. (1.115)
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Example 6: linear problem in three-dimensions with homogeneous Dirichlet boundary
conditions












+ 0.2u, (x, y, z) ∈ Ω = {0 < x < 2π,
π/2 < y < 5π/2, π/2 < z < 5π/2};
u(0, y, z, t) = u(2π, y, z, t) = 0;
u(x, π/2, z, t) = u(x, 5π/2, z, t) = 0;
u(x, y, π/2, t) = u(x, y, 5π/2, t) = 0;
u(x, y, z, 0) = sin x cos y cos z.
(1.116)
The exact solution of the system is
u(x, y, z, t) = e−0.1t sin x cos y cos z. (1.117)
Example 7: linear problem in three-dimensions with homogeneous Neumann boundary
conditions












+ 0.1u, (x, y, z) ∈ Ω = {0 < x < 2π,
π/2 < y < 5π/2, π/2 < z < 5π/2};
∂u
∂x
(0, y, z, t) = ∂u
∂x
(2π, y, z, t) = 0;
∂u
∂y
(x, π/2, z, t) = ∂u
∂y
(x, 5π/2, z, t) = 0;
∂u
∂z
(x, y, π/2, t) = ∂u
∂z
(x, y, 5π/2, t) = 0;
u(x, y, z, 0) = cos x+ sin y + sin z.
(1.118)
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The exact solution of the system is
u(x, y, t) = e−0.1t(cosx+ sin y + sin z). (1.119)
Example 8: linear problem in three-dimensions with inhomogeneous Dirichlet bound-
ary conditions












+ 0.2u, (x, y, z) ∈ Ω = {π/2 < x < 5π/2,
0 < y < 2π, 0 < z < 2π};
u(π/2, y, z, t) = u(5π/2, y, z, t) = e−0.1t cos y cos z;
u(x, 0, z, t) = u(x, 2π, z, t) = e−0.1t sin x cos z;
u(x, y, 0, t) = u(x, y, 2π, t) = e−0.1t sin x cos y;
u(x, y, z, 0) = sin x cos y cos z.
(1.120)
The exact solution of the system is
u(x, y, z, t) = e−0.1t sin x cos y cos z. (1.121)
1.5 Conclusions
In high spatial dimensions, the compact representation of integration factor approach
was found to be very efficient for solving systems involving high-order spatial deriva-
tives and reactions with drastically different time scales, which in general demand
temporal schemes with severe stability constraints. In general, it is difficult to de-
velop cIIF with high order accuracy, especially for inhomogeneous boundary condi-
tions. In this chapter , we have developed a cIIF method for solving a class of stiff
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Table 1.3: Error, order, and CPU time results of the two-dimensional examples.
Nx ×Ny ×Nt Error Order CPU Time (s)
Example 1
20× 20× 640 3.28× 10−4 - 0.10
40× 40× 640 9.08× 10−6 5.18 0.45
80× 80× 640 2.04× 10−7 5.48 2.57
160× 160× 640 9.93× 10−9 4.36 15.43
Example 2
20× 20× 640 2.09× 10−3 - 0.25
40× 40× 640 9.27× 10−5 4.49 0.83
80× 80× 640 3.00× 10−6 4.95 5.16
160× 160× 640 1.48× 10−7 4.34 29.68
Example 3
20× 20× 640 2.02× 10−4 - 0.09
40× 40× 640 1.21× 10−5 4.06 0.35
80× 80× 640 4.72× 10−7 4.68 2.49
160× 160× 640 1.61× 10−8 4.87 14.99
Example 4
20× 20× 640 2.13× 10−3 - 0.20
40× 40× 640 6.24× 10−5 5.09 1.08
80× 80× 640 1.52× 10−5 2.04 5.03
160× 160× 640 7.96× 10−7 4.26 27.92
Example 5
20× 20× 1280 2.31× 10−4 - 1.52
40× 40× 1280 5.35× 10−6 5.43 4.74
80× 80× 1280 2.47× 10−7 4.44 23.73
reaction-diffusion systems for inhomogeneous boundary conditions with fourth order
accuracy in space [16]. In this approach, the stability condition and computational
savings and storage are similar to the original cIIF with second order accuracy.
Although the high order IF method has been presented only in the context of
implicit integration factor methods for reaction-diffusion equations, such approach
can easily be applied to other integration factor or exponential difference methods.
Other type of equations of high-order derivatives, (e.g. Cahn-Hilliard equations of
fourth-order derivatives) may also potentially be handled using the approach for bet-
ter efficiency. To better deal with high spatial dimensions, one may incorporate the
sparse grid [18, 19] into the compact representation technique. The flexibility of com-
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Table 1.4: Error, order, and CPU time results of the three-dimensional examples.
Nx ×Ny ×Nz ×Nt Error Order CPU Time (s)
Example 6
20× 20× 20× 640 4.93× 10−4 - 17.33
40× 40× 40× 640 1.36× 10−5 5.18 96.14
80× 80× 80× 640 3.06× 10−7 5.48 872.26
160× 160× 160× 640 1.49× 10−8 4.36 9670.20
Example 7
20× 20× 20× 640 1.99× 10−4 - 14.66
40× 40× 40× 640 1.20× 10−5 4.05 85.02
80× 80× 80× 640 4.69× 10−7 4.67 824.93
160× 160× 160× 640 1.60× 10−8 4.87 9349.11
Example 8
20× 20× 20× 1280 2.53× 10−4 - 351.10
40× 40× 40× 1280 5.53× 10−6 5.52 3120.31
80× 80× 80× 1280 5.53× 10−7 3.32 38662.07
pact representation allows either direct calculation of the exponentials of matrices or
using Krylov subspace [20–22] for non-constant diffusion coefficients to compute their
exponential matrix-vector multiplications for saving further in storages and cost. In
addition, the presented approach based on the finite difference framework for spatial
discretization could also be extended to other discretization methods such as finite
volume [23–25] or spectral methods [26, 27]. Overall, the compact representation
along with integration factor methods provides an efficient approach for solving a
wide range of problems arising from biological and physical applications. Given to
its effectiveness in implementation and good stability conditions, the method is very
desirable to be incorporated with local adaptive mesh refinement [10, 28, 29], which
will also be further explored in future work.
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Chapter 2
Stability analysis of mathematical models for
nonlinear growth kinetics of breast cancer
stem cells1
2.1 Introduction
Many cancer patients, including those with breast cancer, suffer from the resurgence
of tumors despite receiving various forms of therapy [31]. Since tumors comprise
of heterogeneous cell types, researchers propose the cancer stem cell hypothesis to
explain the survival and reformation of tumors. This hypothesis attributes tumor
resurgence to a small subset of tumor cells, called cancer stem cells (CSCs), which
can survive treatment, self-renew, and differentiate to form the heterogeneous bulk of
a tumor [32, 33]. As a result of their tumorigenicity, CSCs are a potential target in
conjunction with current therapy for more effective cancer treatment [34, 35]. Math-
ematical modeling is employed to study the growth kinetics of breast CSCs. Such
models aid in understanding factors involved in tumor growth and consequentially
provide implications for CSC targeted therapy [36–39].
This chapter is largely motivated by the papers [40] and [37]. In [40], via the
contraction fixed point theorem, the authors obtained the exponential stability in
mean square of the stochastic neutral cellular neural network. In [37], by proposing a
mathematical model with three types of tumor cells, the authors explored the growth
130.
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kinetics of CSC population both in vitro and in vivo. In this chapter, we generalize
the model as in [37] to n-cell types with generic coefficient functions. We prove the
existence of a unique solution of this system of functional differential equations and
study its stability. We then apply these theorems to the specific model that was used
in [37]. We conclude with numerical simulations of the model. Consistent with the
theories, our numerical examples show that the time delays can disrupt the stability
[30].
The chapter is organized as follows. In Section 2.2, some definitions and theorems
are introduced in preliminaries. In Section 2.3, we prove the existence and uniqueness
of the solution for a generalized model of non-linear growth kinetics of breast cancer
stem cells. In Section 2.4, The stability of solutions is studied. In Section 2.5, some
examples are given to demonstrate the results. Numerical examples are presented in
Section 2.6. Finally we conclude the paper.
2.2 Preliminaries
Here we consider the generalized system of functional differential equations with time
delays for the non-linear growth kinetics of breast cancer stem cells
dx0(t)
dt
= [P0(xn−1(t− τ))−Q0(xn−1(t− τ))]ν0(xn−1(t− τ))x0(t)− d0x0(t),
dx1(t)
dt
= [1− P0(xn−1(t− τ)) +Q0(xn−1(t− τ))]ν0(xn−1(t− τ))x0(t)




= [1− Pn−3(xn−1(t− τ)) +Qn−3(xn−1(t− τ))]νn−3(xn−1(t− τ))xn−3(t)




= [1− Pn−2(xn−1(t− τ)) +Qn−2(xn−1(t− τ))]νn−2(xn−1(t− τ))xn−2(t)
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− dn−1xn−1(t) (1.1)
for n ≥ 2. Here we denote xi(t) the number of cells at time t for cell types i, i =
0, 1, · · · , n− 1. Pi the probability that the cell type i is divided into a pair of itself,
Qi the probability that the cell type i is divided into a pair of next cell lineage (cell
type i+1). Thus 1−Pi−Qi denotes the probability that an asymmetric cell division
takes place from cell type i to cell type i − 1. Here vi is the synthesis rate which
quantifies the speed for cell type i to divide in unit time, di is the degradation rate.
Here τ is a positive constant, Pi > 0, Qi > 0, νi > 0 (i = 0, 1, 2, · · · , n − 2) are
all decreasing functions of xn−1, which represents the negative feedback from the
terminally differentiated cell type n− 1.
Since Pi, Qi, and νi (i = 0, 1, 2, · · · , n− 2) are decreasing functions of xn−1, there
exist some positive constants P i, Qi, and νi such that
Pi(xn−1) ≤ P i, Qi(xn−1) ≤ Qi, νi(xn−1) ≤ νi for i = 0, 1, 2, · · · , n− 2.
(1.2)
In fact, (1.1) can be written in the more general form
ẋ(t) = f(t, x(t), x(t− τ)) (1.3)
with the initial condition
x(s) = φ(s) ∈ C([t0 − τ, t0];Rn), t0 − τ ≤ s ≤ t0, (1.4)
where τ is a constant and x(t) = (x0(t), x1(t), · · · , xn−1(t))T is the state vector.
















The following definitions in [41] will be used to describe the stability of steady
state solution. Suppose f(t, 0) = 0 for all t ∈ R.
Definition 2.1. The solution x = 0 of Equation (1.3) is said to be stable if for all
t0 ∈ R and ε > 0, there exists a δ > 0 such that if ‖φ‖2 < δ, then |x(t)|1 < ε for
t ≥ t0.
Definition 2.2. The solution x = 0 of Equation (1.3) is said to be asymptotically
stable if it is stable and for all t0 ∈ R, there exists a b0 > 0 such that if ‖φ‖2 < b0,
then x(t)→ 0 as t→∞.
Definition 2.3. The solution x = 0 of Equation (1.3) is said to be uniformly stable
if the number δ in the definition of stable is independent of t0, i.e., for all ε > 0, there
exists a δ > 0 such that if ‖φ‖2 < δ for some t0 ∈ R, then |x(t)|1 < ε for t ≥ t0.
Definition 2.4. The solution x = 0 of Equation (1.3) is said to be uniformly
asymptotically stable if it is uniformly stable and there exists a b0 > 0 such that for
every η > 0, there exists an s > 0 such that if ‖φ‖2 < b0, then |x(t)|1 < η for t ≥ t0 +s
for all t0 ∈ R.
The following theorem in [41] will be used to give sufficient conditions for the
existence and uniqueness of the solution for the system (1.3).
Theorem A. Suppose Ω is an open set in R × C, f : Ω → Rn is continuous, and
f(t, φ) is Lipschitzian in φ in each compact set in Ω. If (t, φ) ∈ Ω, then there is a
unique solution of Equation (1.3) through (t, φ).
If V : R × C → R is continuous and x(t, φ) is the solution of Equation (1.3)
through (t, φ), we define




[V (t+ h, xt+h(t, φ))− V (t, φ)].
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The function V̇ (t, φ) is the upper right-hand derivative of V (t, φ) along the solution
of x(t, φ).
The following method of Liapunov functionals in [41] will be used to give sufficient
conditions for the stability of the solution x = 0 for the system (1.3).
Theorem B. Suppose f : R×C → Rn takes R×(bounded sets of C) into bounded
sets of Rn, µ, ν, ω : R+ → R+ are continuous nondecreasing functions, µ(s) and ν(s)
are positive for s > 0, and µ(0) = ν(0) = 0. If there is a continuous function
V : R× C → R such that
µ(|x|1) ≤ V (t, x) ≤ ν(‖x‖2)
and
V̇ (t, x) ≤ −ω(|x|1).
Then the solution x = 0 of Equation (1.3) is uniformly stable. If µ(s) → ∞ as
s→∞, the solutions of Equation (1.3) are uniformly bounded. If ω(s) > 0 for s > 0,
then the solution x = 0 is uniformly asymptotically stable.
2.3 Existence of solutions for non-linear growth kinetics of
breast cancer stem cells
Theorem 3.1. Suppose Ω is an open set in R × C. If (t, φ) ∈ Ω, then there is a
unique solution of Equation (1.1) through (t, φ).
Proof: Firstly, we have from (1.1) that
ẋ(t) = F (t, x(t), x(t− τ))−Dx(t) (3.1)
with the initial condition
x(s) = φ(s) ∈ C([t0 − τ, t0];Rn), t0 − τ ≤ s ≤ t0, (3.2)
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where x(t) = (x0(t), x1(t), · · · , xn−1)T , D = diag(d0, d1, · · · , dn−1),


















[P0(xn−1(t− τ))−Q0(xn−1(t− τ))]ν0(xn−1(t− τ))x0(t)
[1− P0(xn−1(t− τ)) +Q0(xn−1(t− τ))]ν0(xn−1(t− τ))x0(t)+
[P1(xn−1(t− τ))−Q1(xn−1(t− τ))]ν1(xn−1(t− τ))x1(t)
...
[1− Pn−3(xn−1(t− τ)) +Qn−3(xn−1(t− τ))]νn−3(xn−1(t− τ))xn−3(t)+
[Pn−2(xn−1(t− τ))−Qn−2(xn−1(t− τ))]νn−2(xn−1(t− τ))xn−2(t)





[P0 −Q0]ν0 0 · · ·
[1− P0 +Q0]ν0 [P1 −Q1]ν1 · · ·
... ... . . .
0 0 · · ·
0 0 · · ·
· · · 0 0 0
· · · 0 0 0
. . . ... ... ...
· · · [1− Pn−3 +Qn−3]νn−3 [Pn−2 −Qn−2]νn−2 0




Obviously we have from (1.2) and the definitions of | · |1, ‖ · ‖2, and ‖ · ‖3 that













This implies that F (t, x(t), x(t− τ)) satisfies the Lipschitzian condition in x(t). Thus
there exists a unique solution of Equation (1.1) by Theorem A.
Remark 3.2. There also exists a unique solution of Equation (1.1) when the time
delay is τ = 0.
2.4 Stability of solutions for non-linear growth kinetics of breast
cancer stem cells
Theorem 4.1. The solution x = 0 of Equation (1.1) is uniformly asymptotically
stable if
(1 + 2P 0 +Q0)ν0 ≤ 2d0,
(1 +Q0)ν0 + (1 + 2P 1 +Q1)ν1 ≤ 2d1,
...
(1 +Qn−3)νn−3 + (1 + 2P n−2 +Qn−2)νn−2 ≤ 2dn−2,
(1 +Qn−2)νn−2 ≤ 2dn−1.
Proof: Let
V (t, x(t)) = 12(x
2
0(t) + x21(t) + · · ·+ x2n−1(t)). (4.1)
Then
µ(|x|1) ≤ V (t, x) ≤ ν(‖x‖2)
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with, for example, µ(s) = 12ns
2 and ν(s) = s2. We have from (1.1), (1.2), and (4.1)
that




1(t) + · · ·+ xn−1(t)x
′
n−1(t)] (4.2)
= [P0(xn−1(t− τ))−Q0(xn−1(t− τ))]ν0(xn−1(t− τ))x20(t)− d0x20(t)
+ [1− P0(xn−1(t− τ)) +Q0(xn−1(t− τ))]ν0(xn−1(t− τ))x0(t)x1(t)
+ [P1(xn−1(t− τ))−Q1(xn−1(t− τ))]ν1(xn−1(t− τ))x21(t)− d1x21(t) + · · ·
+ [1− Pn−3(xn−1(t− τ)) +Qn−3(xn−1(t− τ))]νn−3(xn−1(t− τ))xn−3(t)xn−2(t)
+ [Pn−2(xn−1(t− τ))−Qn−2(xn−1(t− τ))]νn−2(xn−1(t− τ))x2n−2(t)
− dn−2x2n−2(t) + [1− Pn−2(xn−1(t− τ)) +Qn−2(xn−1(t− τ))]
× νn−2(xn−1(t− τ))xn−2(t)xn−1(t)− dn−1x2n−1(t)
≤ {[P0(xn−1(t− τ))−Q0(xn−1(t− τ))]ν0(xn−1(t− τ))− d0
+ 12 |[1− P0(xn−1(t− τ)) +Q0(xn−1(t− τ))]ν0(xn−1(t− τ))|}x
2
0(t)
+ {12 |[1− P0(xn−1(t− τ)) +Q0(xn−1(t− τ))]ν0(xn−1(t− τ))| − d1
+ [P1(xn−1(t− τ))−Q1(xn−1(t− τ))]ν1(xn−1(t− τ))
+ 12 |[1− P1(xn−1(t− τ)) +Q1(xn−1(t− τ))]ν1(xn−1(t− τ))|}x
2
1(t) + · · ·
+ {12 |[1− Pn−3(xn−1(t− τ)) +Qn−3(xn−1(t− τ))]νn−3(xn−1(t− τ))| − dn−2
+ [Pn−2(xn−1(t− τ))−Qn−2(xn−1(t− τ))]νn−2(xn−1(t− τ))
+ 12 |[1− Pn−2(xn−1(t− τ)) +Qn−2(xn−1(t− τ))]νn−2(xn−1(t− τ))|}x
2
n−2(t)
+ {12 |[1− Pn−2(xn−1(t− τ)) +Qn−2(xn−1(t− τ))]νn−2(xn−1(t− τ))|
− dn−1}x2n−1(t)
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≤ {P 0ν0 +
1
2 |[1 +Q0]ν0| − d0}x
2
0(t)
+ {12 |[1 +Q0]ν0|+ P 1ν1 +
1
2 |[1 +Q1]ν1| − d1}x
2
1(t) + · · ·
+ {12 |[1 +Qn−3]νn−3|+ P n−2νn−2 +
1
2 |[1 +Qn−2]νn−2| − dn−2}x
2
n−2(t)
+ {12 |[1 +Qn−2]νn−2| − dn−1}x
2
n−1(t).




2 |[1 +Q0]ν0| − d0 ≤ 0, (4.3)
1
2 |[1 +Q0]ν0|+ P 1ν1 +
1
2 |[1 +Q1]ν1| − d1 ≤ 0,
...
1
2 |[1 +Qn−3]νn−3|+ P n−2νn−2 +
1
2 |[1 +Qn−2]νn−2| − dn−2 ≤ 0,
1
2 |[1 +Qn−2]νn−2| − dn−1 ≤ 0,
which implies
(1 + 2P 0 +Q0)ν0 ≤ 2d0, (4.4)
(1 +Q0)ν0 + (1 + 2P 1 +Q1)ν1 ≤ 2d1,
...
(1 +Qn−3)νn−3 + (1 + 2P n−2 +Qn−2)νn−2 ≤ 2dn−2,
(1 +Qn−2)νn−2 ≤ 2dn−1.
Remark 4.2. Theorem 4.1 still holds when τ = 0.
We have another uniform asymptotic stability theorem about Equation (1.1) by
using the method of characteristic equation when τ = 0.
Theorem 4.3. Suppose (x∗0, x∗1 · · · , x∗n−1) is a steady state solution of Equation
(1.1) with τ = 0. Then this steady state solution is uniformly asymptotically stable
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if the roots of the characteristic equation
det[λI − A] = 0
satisfy Reλ < 0, where
A =

a1,1 0 0 · · · 0 a1,n
a2,1 a2,2 0 · · · 0 a2,n
... ... ... . . . ... ...
0 0 0 · · · an−1,n−1 an−1,n




a2,1 = ν0(x∗n−1)[1− P0(x∗n−1) +Q0(x∗n−1)],
a2,2 = [P1(x∗n−1)−Q1(x∗n−1)]ν1(x∗n−1)− d1,
...
an−1,n−2 = νn−3(x∗n−1)[1− Pn−3(x∗n−1) +Qn−3(x∗n−1)],
an−1,n−1 = [Pn−2(x∗n−1)−Qn−2(x∗n−1)]νn−2(x∗n−1)− dn−2,














































+ (1− Pn−2(x∗n−1) +Qn−2(x∗n−1))ν
′
n−2(x∗n−1)].













= ν0(x∗n−1)[1− P0(x∗n−1) +Q0(x∗n−1)]x0(t) + {[P1(x∗n−1)
−Q1(x∗n−1)]ν1(x∗n−1)− d1}x1(t) + {x∗0[(−P
′
0(x∗n−1)














= νn−3(x∗n−1)[1− Pn−3(x∗n−1) +Qn−3(x∗n−1)]xn−3(t) + {[Pn−2(x∗n−1)
−Qn−2(x∗n−1)]νn−2(x∗n−1)− dn−2}xn−2(t) + {x∗n−3[(−P
′
n−3(x∗n−1)






















We have from (4.5) that
Ẋ(t) = AX(t). (4.6)
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Therefore the steady state solution (x∗0, x∗1, · · · , x∗1) of Equation (1.1) with τ = 0 is
uniformly asymptotically stable if the roots of the characteristic equation
det[λI − A] = 0 (4.7)
satisfy Reλ < 0.
Theorem 4.4. Suppose (x∗0, x∗1 · · · , x∗n−1) is a steady state solution of Equation
(1.1). Then this steady state solution is uniformly asymptotically stable if the roots
of the characteristic equation
det[λI − A−Be−λτ ] = 0
satisfy Reλ < 0, where
A =

a11 0 0 · · · 0 0
a21 a22 0 · · · 0 0
... ... ... . . . ... ...
0 0 0 · · · an−1,n−1 0





0 0 · · · 0 b1n
0 0 · · · 0 b2n
... ... . . . ... ...




a2,1 = ν0(x∗n−1)[1− P0(x∗n−1) +Q0(x∗n−1)],
a2,2 = [P1(x∗n−1)−Q1(x∗n−1)]ν1(x∗n−1)− d1,
...
an−1,n−2 = νn−3(x∗n−1)[1− Pn−3(x∗n−1) +Qn−3(x∗n−1)],
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an−1,n−1 = [Pn−2(x∗n−1)−Qn−2(x∗n−1)]νn−2(x∗n−1)− dn−2,





























































= ν0(x∗n−1)[1− P0(x∗n−1) +Q0(x∗n−1)]x0(t) + {[P1(x∗n−1)−


















= νn−3(x∗n−1)[1− Pn−3(x∗n−1) +Qn−3(x∗n−1)]xn−3(t) + {[Pn−2(x∗n−1)


























where (x∗0, x∗1 · · · , x∗n−1) is a steady state solution of Equation (1.1).
We have from (4.8) that
Ẋ(t) = AX(t) +BX(t− τ).
Therefore the steady state solution (x∗0, x∗1, · · · , x∗n−1) of Equation (1.1) is uniformly
asymptotically stable if the roots of the characteristic equation
det[λI − A−Be−λτ ] = 0 (4.9)
satisfy Reλ < 0.
In order to guarantee that the roots of the characteristic equation (4.9) are in the
left half-plane, the following result in [41] will be applied.
Theorem 4.5. Let 4(z) = P (z, ez) where P (z, w) is a polynomial with principal
term. Suppose 4(iy), y ∈ R, is separated into its real and imaginary parts, 4(iy) =
F (y) + iG(y). If all zeros of 4(z) have negative real parts, then the zeros of F (y)
and G(y) are real, simple, and alternate and
G
′(y)F (y)−G(y)F ′(y) > 0 for y ∈ R. (4.10)
Conversely, all zeros of 4(z) will be in the left half-plane provided that either of the
following conditions is satisfied:
(i) All the zeros of F (y) and G(y) are real, simple, and alternate and Inequality
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(4.10) is satisfied for at least one y.
(ii) All the zeros of F (y) are real and, for each zero, Relation (4.10) is satisfied.
(iii) All the zeros of G(y) are real and, for each zero, Relation (4.10) is satisfied.
Let
4(λ) = det[λI − A−Be−λτ ]. (4.11)
Therefore we have:
Theorem 4.6. Suppose (x∗0, x∗1 · · · , x∗n−1) is a steady state solution of Equation
(1.1). Then this steady state solution is uniformly asymptotically stable if (4.11)
satisfies either condition (i), (ii), or (iii) of Theorem 4.5.
2.5 Examples
We consider the following two special cases of (1.1)
dx0(t)
dt
= [ p01 + γ01(x2(t− τ))2
− q01 + γ02(x2(t− τ))2




= [1− p01 + γ01(x2(t− τ))2
+ q01 + γ02(x2(t− τ))2






= [ p01 + γ01(x2(t− τ))2
− q01 + γ02(x2(t− τ))2




= [1− p01 + γ01(x2(t− τ))2
+ q01 + γ02(x2(t− τ))2
] ν01 + β0(x2(t− τ))2
x0(t)
+ [ p11 + γ11(x2(t− τ))2
− q11 + γ12(x2(t− τ))2





= [1− p11 + γ11(x2(t− τ))2
+ q11 + γ12(x2(t− τ))2




Theorem 5.1. Suppose Ω is an open set in R×C, p0 ≥ 0, q0 ≥ 0, γ01 ≥ 0, γ02 ≥ 0,
ν0 ≥ 0, and β0 ≥ 0. If (t, φ) ∈ Ω, then there is a unique solution of Equation (5.1)
through (t, φ).
Proof. Firstly, we have from (5.1) that
ẋ(t) = −Dx(t) + F (t, x(t), x(t− τ)) (5.3)
with the initial condition
x(s) = φ(s) ∈ C([−τ, 0];R2), −τ ≤ s ≤ 0, (5.4)
where x(t) = (x0(t), x2(t))T , D = diag(d0, d2),
F (t, x(t), x(t− τ)) =
 f1
f2




























Obviously we have that
‖F (t, x(t), x(t− τ))‖2 ≤ ‖A‖3|x|1 ≤ (ν0(1 + 2p0 + 2q0)|x|1. (5.5)
This implies that F (t, x(t), x(t− τ)) satisfies the Lipschitzian condition in x(t). Thus
there exists a unique solution of Equation (5.1) by Theorem A.
Remark 5.2. There also exists a unique solution of Equation (5.1) when the time
delay is τ = 0.
Remark 5.3. Obviously, P0(x2) = p01+γ01(x2)2 , Q0(x2) =
q0
1+γ02(x2)2
, and ν0(x2) =
ν0
1+β0(x2)2 are decreasing functions of x2.
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Theorem 5.4. Suppose Ω is an open set in R× C, pj ≥ 0, qj ≥ 0, βj ≥ 0, νj ≥ 0,
and γji ≥ 0 (i = 1, 2, j = 0, 1). If (t, φ) ∈ Ω, then there is a unique solution of
Equation (5.2) through (t, φ).
Proof. Similar to (5.3) and (5.4), we have
ẋ(t) = −Dx(t) + F (t, x(t), x(t− τ)) (5.6)
with the initial condition
x(s) = φ(s) ∈ C([−τ, 0];R3), −τ ≤ s ≤ 0, (5.7)
where x(t) = (x0(t), x1(t), x2(t))T , D = diag(d0, d1, d2),

































[1− P0(x2) +Q0(x2)]ν0(x2) [P1(x2)−Q1(x2)]ν1(x2) 0
0 [1− P1(x2) +Q1(x2)]ν1(x2) 0
 ,
Pi(x2) = pi1+γi1(x2)2 , Qi(x2) =
qi
1+γi2(x2)2
, and νi(x2) = νi1+βi(x2)2 (i = 0, 1).
Obviously we have that
‖F (t, x(t), x(t− τ))‖2 ≤ ‖A‖3|x|1 ≤ [ν0(1 + 2p0 + 2q0) + ν1(1 + 2p1 + 2q1)]|x|1.
(5.8)
This implies that F (t, x(t), x(t− τ)) satisfies the Lipschitzian condition in x(t). Thus
there exists a unique solution of Equation (5.2) by Theorem A.
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Remark 5.5. There also exists a unique solution of Equation (5.2) when the time
delay is τ = 0.
Remark 5.6. Obviously, Pi(x2) = pi1+γi1(x2)2 , Qi(x2) =
qi
1+γi2(x2)2
, and νi(x2) =
νi
1+βi(x2)2 (i = 0, 1) are decreasing functions of x2.
Theorem 5.7. Suppose (1 + 2p0 + q0)ν0 ≤ 2d0 and (1 + q0)ν0 ≤ 2d2. Then the
solution x = 0 of Equation (5.1) is uniformly asymptotically stable.
Proof. Let
V (t, x(t)) = 12(x
2
0(t) + x22(t)). (5.9)
Then
V ′ = [ p01 + γ01(x2(t− τ))2
− q01 + γ02(x2(t− τ))2
] ν01 + β0(x2(t− τ))2
x20(t)
− d0x20(t)− d2x22(t)
+ [1− p01 + γ01(x2(t− τ))2
+ q01 + γ02(x2(t− τ))2
] ν01 + β0(x2(t− τ))2
x0(t)x2(t)
≤ [ p01 + γ01(x2(t− τ))2
− q01 + γ02(x2(t− τ))2
] ν01 + β0(x2(t− τ))2
x20(t)
− d0x20(t)− d2x22(t)
+ |[1− p01 + γ01(x2(t− τ))2
+ q01 + γ02(x2(t− τ))2





= {[ p01 + γ01(x2(t− τ))2
− q01 + γ02(x2(t− τ))2




1 + γ01(x2(t− τ))2
+ q01 + γ02(x2(t− τ))2




1 + γ01(x2(t− τ))2
+ q01 + γ02(x2(t− τ))2
] ν01 + β0(x2(t− τ))2
| − d2}x22(t).
(5.10)
Then the solution x = 0 of Equation (5.1) is uniformly asymptotically stable by
Theorem B if
[ p01 + γ01(x2(t− τ))2
− q01 + γ02(x2(t− τ))2




1 + γ01(x2(t− τ))2
+ q01 + γ02(x2(t− τ))2






1 + γ01(x2(t− τ))2
+ q01 + γ02(x2(t− τ))2
] ν01 + β0(x2(t− τ))2
| − d2 ≤ 0. (5.11)
Then a sufficient condition can be taken,
(1 + 2p0 + q0)ν0 ≤ 2d0,
(1 + q0)ν0 ≤ 2d2. (5.12)
Remark 5.8. Theorem 5.7 still holds when τ = 0.
Remark 5.9. Obviously, Theorem 5.7 is a special case of Theorem 4.1.
We have another uniform asymptotic stability theorem about Equation (5.1) by
using the method of characteristic equation when τ = 0 as the following.
Theorem 5.10. Suppose (x∗0, x∗2) is a steady state solution of Equation (1.1) with
τ = 0. Then this steady state solution is uniformly asymptotically stable if














1− p01 + γ01(x∗2)2







1− p01 + γ01(x∗2)2



























































1− p01 + γ01(x∗2)2




















1− p01 + γ01(x∗2)2






where (x∗0, x∗2) is a steady state solution of Equation (5.1) with τ = 0.
We have from (5.13) that

































1− p01 + γ01(x∗2)2



















1− p01 + γ01(x∗2)2






Therefore the steady state solution (x∗0, x∗2) of Equation (5.1) with τ = 0 is uniformly
asymptotically stable if the roots of the characteristic equation
det[λI − A] = λ2 − (a1 + a4)λ+ a1a4 − a2a3 = 0 (5.16)
satisfy Reλ < 0.
Then we have from (5.14)–(5.16) that















1− p01 + γ01(x∗2)2







1− p01 + γ01(x∗2)2




























Theorem 5.11. The steady state solution of Equation (5.1) is uniformly asymp-
totically stable provided that
F (y) = −y2 − a4y sin yτ + (a1a4 − a2a3) cos yτ − a1d2
and
G(y) = y(d2 − a1 − a4 cos yτ) + (a2a3 − a1a4) sin yτ




























1− p01 + γ01(x∗2)2



















1− p01 + γ01(x∗2)2






































1− p01 + γ01(x∗2)2



















1− p01 + γ01(x∗2)2






We have from (5.19) that









Then we have the characteristic equation of Equation (5.1)
det[λI−A−Be−λτ ] = λ2+(d2−a1−a4e−λτ )λ−(d2−a4e−λτ )a1−a2a3e−λτ = 0. (5.22)
If4(λ) = λ2 +(d2−a1−a4e−λτ )λ−(d2−a4e−λτ )a1−a2a3e−λτ , 4(iy) = F (y)+iG(y),
y ∈ R, then
F (y) = −y2 − a4y sin yτ + (a1a4 − a2a3) cos yτ − a1d2,
G(y) = y(d2 − a1 − a4 cos yτ) + (a2a3 − a1a4) sin yτ.
(5.23)
By Theorem 4.4, the steady state solution of Equation (5.1) is uniformly asymptot-
ically stable provided that equation (5.23) satisfies either condition (i), (ii), or (iii)
of Theorem 4.5.
Theorem 5.12. Suppose (1+2p0 + q0)ν0 ≤ 2d0, (1+ q0)ν0 +(1+2p1 + q1)ν1 ≤ 2d1,
and (1 + q1)ν1 ≤ 2d2. Then the solution x = 0 of Equation (5.2) is uniformly asymp-
totically stable.
Proof. Let
V (t, x(t)) = 12(x
2
0(t) + x21(t) + x22(t)). (5.24)
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Then
V ′ = [ p01 + γ01(x2(t− τ))2
− q01 + γ02(x2(t− τ))2
] ν01 + β0(x2(t− τ))2
x20(t)
− d0x20(t)
+ [1− p01 + γ01(x2(t− τ))2
+ q01 + γ02(x2(t− τ))2
] ν01 + β0(x2(t− τ))2
x0(t)x1(t)
+ [ p11 + γ11(x2(t− τ))2
− q11 + γ12(x2(t− τ))2
] ν11 + β1(x2(t− τ))2
x21(t)
− d1x21(t)
+ [1− p11 + γ11(x2(t− τ))2
+ q11 + γ12(x2(t− τ))2
] ν11 + β1(x2(t− τ))2
x1(t)x2(t)
− d2x22(t)
≤ [ p01 + γ01(x2(t− τ))2
− q01 + γ02(x2(t− τ))2
] ν01 + β0(x2(t− τ))2
x20(t)
− d0x20(t)
+ |[1− p01 + γ01(x2(t− τ))2
+ q01 + γ02(x2(t− τ))2





+ [ p11 + γ11(x2(t− τ))2
− q11 + γ12(x2(t− τ))2
] ν11 + β1(x2(t− τ))2
x21(t)
− d1x21(t)
+ |[1− p11 + γ11(x2(t− τ))2
+ q11 + γ12(x2(t− τ))2






= {[ p01 + γ01(x2(t− τ))2
− q01 + γ02(x2(t− τ))2




1 + γ01(x2(t− τ))2
+ q01 + γ02(x2(t− τ))2





1 + γ01(x2(t− τ))2
+ q01 + γ02(x2(t− τ))2
] ν01 + β0(x2(t− τ))2
|
+ [ p11 + γ11(x2(t− τ))2
− q11 + γ12(x2(t− τ))2




1 + γ11(x2(t− τ))2
+ q11 + γ12(x2(t− τ))2




1 + γ11(x2(t− τ))2
+ q11 + γ12(x2(t− τ))2
] ν11 + β1(x2(t− τ))2
| − d2}x22(t)
(5.25)
Then the solution x = 0 of Equation (5.2) is uniformly asymptotically stable by
Theorem B if
[ p01 + γ01(x2(t− τ))2
− q01 + γ02(x2(t− τ))2
+12 |1−
p0
1 + γ01(x2(t− τ))2
+ q01 + γ02(x2(t− τ))2
|]
× ν01 + β0(x2(t− τ))2
− d0 ≤ 0,
[ p11 + γ11(x2(t− τ))2
− q11 + γ12(x2(t− τ))2
+12 |1−
p1
1 + γ11(x2(t− τ))2
+ q11 + γ12(x2(t− τ))2
|]
× ν11 + β1(x2(t− τ))2
+12 |1−
p0
1 + γ01(x2(t− τ))2
+ q01 + γ02(x2(t− τ))2
|
× ν01 + β0(x2(t− τ))2




1 + γ11(x2(t− τ))2
+ q11 + γ12(x2(t− τ))2
]
× ν11 + β1(x2(t− τ))2
| − d2 ≤ 0. (5.26)
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Then a sufficient condition can be taken,
(1 + 2p0 + q0)ν0 ≤ 2d0,
(1 + q0)ν0 + (1 + 2p1 + q1)ν1 ≤ 2d1,
(1 + q1)ν1 ≤ 2d2. (5.27)
Remark 5.13. Theorem 5.11 still holds when τ = 0.
Remark 5.14. Obviously, Theorem 5.11 is a special case of Theorem 4.1.
Theorem 5.15. The steady state solution of Equation (5.2) is uniformly asymp-
totically stable provided that
F (y) = [(a5 + a3 + a1) + b3 cos yτ ]y2 + y(a3b3 − b2a4 + a1b3) sin yτ − a1a3a5
−[b1a2a4 + a1(a3b3 − b2a4)] cos yτ
and
G(y) = −y3 − (b3 sin yτ)y2 + [a3a5 + a1(a5 + a3) + (a3b3 − b2a4 + a1b3) cos yτ ]y
+[b1a2a4 + a1(a3b3 − b2a4)] sin yτ.





+ q01 + γ02(x∗2)2





− q11 + γ12(x∗2)2





+ q11 + γ12(x∗2)2















− [ p01 + γ01(x∗2)2
− q01 + γ02(x∗2)2

















− [1− p01 + γ01(x∗2)2


















− [ p11 + γ11(x∗2)2


















− [1− p11 + γ11(x∗2)2
+ q11 + γ12(x∗2)2
] 2ν1β1[1 + β1(x∗2)2]2
}.















− [ p01 + γ01(x∗2)2
− q01 + γ02(x∗2)2




= [1− p01 + γ01(x∗2)2
+ q01 + γ02(x∗2)2
] ν01 + β0(x∗2)2
x0(t)
+ {[ p11 + γ11(x∗2)2
− q11 + γ12(x∗2)2
















− [1− p01 + γ01(x∗2)2


















− [ p11 + γ11(x∗2)2








= [1− p11 + γ11(x∗2)2
+ q11 + γ12(x∗2)2















− [1− p11 + γ11(x∗2)2
+ q11 + γ12(x∗2)2
] 2ν1β1[1 + β1(x∗2)2]2
}x2(t− τ)− d2x2(t), (5.28)
where (x∗0, x∗1, x∗2) is a steady state solution of Equation (5.2). We have from (5.28)
that













Then we have the characteristic equation of system (5.2)
det[λI − A−Be−λτ ] = λ3 − [(a5 + a3 + a1) + b3e−λτ ]λ2
+ [a3a5 + a1(a5 + a3) + (a3b3 − b2a4 + a1b3)e−λτ ]λ
− a1a3a5 − [b1a2a4 + a1(a3b3 − b2a4)]e−λτ
= 0. (5.31)
If
4(λ) = λ3 − [(a5 + a3 + a1) + b3e−λτ ]λ2 + [a3a5 + a1(a5 + a3) + (a3b3 − b2a4
+a1b3)e−λτ ]λ− a1a3a5 − [b1a2a4 + a1(a3b3 − b2a4)]e−λτ ,
4(iy) = F (y) + iG(y), y ∈ R, then
F (y) = [(a5 + a3 + a1) + b3 cos yτ ]y2 + y(a3b3 − b2a4 + a1b3) sin yτ − a1a3a5
−[b1a2a4 + a1(a3b3 − b2a4)] cos yτ,
G(y) = −y3 − (b3 sin yτ)y2 + [a3a5 + a1(a5 + a3) + (a3b3 − b2a4 + a1b3) cos yτ ]y
+[b1a2a4 + a1(a3b3 − b2a4)] sin yτ.
(5.32)
By Theorem 4.4, the steady state solution of Equation (5.2) is uniformly asymptoti-
cally stable provided that (5.32) satisfies either condition (i), (ii), or (iii) of Theorem
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4.5.
Theorem 5.16. Suppose (x∗0, x∗1, x∗2) is a steady state solution of Equation (5.2)
with τ = 0. Then this steady state solution is uniformly asymptotically stable if the
roots of the characteristic equation
det[λI − A] = λ3 − (a3 + a6)λ2 + [a3a6 − a4a5]λ− a1a2a5 = 0













− [ p01 + γ01(x∗2)2
− q01 + γ02(x∗2)2





+ q01 + γ02(x∗2)2





− q11 + γ12(x∗2)2
















− [1− p01 + γ01(x∗2)2


















− [ p11 + γ11(x∗2)2









+ q11 + γ12(x∗2)2














− [1− p11 + γ11(x∗2)2
+ q11 + γ12(x∗2)2
] 2ν1β1[1 + β1(x∗2)2]2
} − d2.
















− [ p01 + γ01(x∗2)2
− q01 + γ02(x∗2)2




= [1− p01 + γ01(x∗2)2
+ q01 + γ02(x∗2)2
] ν01 + β0(x∗2)2
x0(t)
+ {[ p11 + γ11(x∗2)2
− q11 + γ12(x∗2)2
















− [1− p01 + γ01(x∗2)2


















− [ p11 + γ11(x∗2)2








= [1− p11 + γ11(x∗2)2
+ q11 + γ12(x∗2)2














− [1− p11 + γ11(x∗2)2
+ q11 + γ12(x∗2)2
] 2ν1β1[1 + β1(x∗2)2]2
}x2(t)− d2x2(t). (5.33)
We have from (5.33) that







 , λI − A =

λ 0 −a1
−a2 λ− a3 −a4
0 −a5 λ− a6
 . (5.35)
Then we have the characteristic equation of Equation (5.2)
det[λI − A] = λ3 − (a3 + a6)λ2 + [a3a6 − a4a5]λ− a1a2a5 = 0. (5.36)
Therefore the steady state solution (x∗0, x∗1, x∗2) of Equation (5.2) with τ = 0 is uni-








= [ p01 + γ01(x2(t− τ))2
− q01 + γ02(x2(t− τ))2




= [1− p01 + γ01(x2(t− τ))2
+ q01 + γ02(x2(t− τ))2
] ν01 + β0(x2(t− τ))2
x0(t)
+ [ p11 + γ11(x2(t− τ))2
+ q11 + γ12(x2(t− τ))2




= [1− p11 + γ11(x2(t− τ))2
+ q11 + γ12(x2(t− τ))2
] ν11 + β1(x2(t− τ))2
x1(t)− d2x2(t),
(6.1)
where x0(t), x1(t), and x2(t) are the number of cancer stem cells (CSCs), progenitor
cells (PCs), and terminally differentiated cells (TDCs), respectively, at time t.
The figures show the solution of (6.1) implemented in MATLAB with initial con-
dition x(0) = (10, 200, 800)T . The parameters used in the figure are listed in Table
(2.1). All of the figures have the same parameters and differ only in the time delay,
τ . The time-delay is 0, 5, 10, and 20 time units for Figures (2.1)a, b, c, and d,
respectively. The x-axis is time units, and the y-axis is number of cells in a log-scale.
The inset shows a zoomed-in portion of the graph.
In Figure (2.1)a, the number of cells quickly grows to about 104 and then levels
off. Stable equilibrium is reached. In Figure (2.1)b, the number of cells quickly grows
to about 106 and then eventually levels off to the same level as Figure (2.1)a. Stable
equilibrium is eventually reached. In Figure (2.1)c, we see similar behavior to Figure
(2.1)b. Dynamic equilibrium is reached, but it is not stable since there are small
oscillations in the number cells around the equilibrium position. In Figure (2.1)d, the
number of cells quickly grows to about 106 and then levels off. This is two orders of
magnitude greater than the previous scenarios. Dynamic equilibrium is reached, but
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it is not stable since there are large oscillations in the number of all cell types around
the equilibrium position. These results suggest that for a given set of parameters, the
time delay disrupts the stability of the steady state solution, with greater time delays
causing greater disruptions. This is reasonable since, from our analysis, the sufficient
conditions for stability of the steady state solution for zero time delay, Theorem 5.16,
vary from those for nonzero time delay, Theorem 5.15. In this case, the threshold
where stability is disrupted is between τ = 5 and τ = 10.
The parameters were chosen both from biological data from our collaborator’s lab
[37] and from requiring that equilibrium is reached. From experiments with tumor
cells we know that the degradation rate is the greatest for TDCs, then PCs, and
then CSCs. We also know that the equilibrium tumor size is roughly 106 total cells.
Additionally, the probabilities, p0, q0, p1, and q1, and degradation rates, d0, d1, and
d2, are between 0 and 1 by definition. With these restrictions, the parameters were
then chosen through guess and check until equilibrium was reached. The parameters
for zero time delay satisfy the conditions of Theorem 5.16.
Table 2.1: Parameters used in Figures (2.1).
Parameter Value Parameter Value Parameter Value
p0 0.5 q0 0.2 ν0 10
p1 0.001 q1 0.9 ν1 10
γ01 7× 10−9 γ02 4× 10−10 β0 3× 10−8
γ11 2× 102 γ12 8× 10−18 β1 2× 10−7
d0 0.001 d1 0.08 d2 0.085
2.7 Conclusion
Cancer stem cells are responsible for tumor survival and resurgence and are thus
essential in developing novel therapeutic strategies against cancer. Mathematical
modeling is employed to study the growth kinetics of breast CSCs. In this chapter,




Figure 2.1: Solution of (6.1). Parameters are listed in Table (2.1). (a) τ = 0. (b)
τ = 5. (c) τ = 10. (d) τ = 20.
kinetics of breast CSCs. By applying a theory from functional and ordinary differen-
tial equations, we proved the existence of unique solutions. By additionally applying
a theorem from complex analysis and using linearization techniques, we have given a
criteria for uniform asymptotic stability of the zero and steady state solutions. These
results were then applied to the specific model that was used in [37]. Numerical
simulations of the model were presented in the end to further show the efficiency of
our results [30]. The results developed in this chapter can potentially aide in under-
standing cancer stem and differentiated cell interaction in tumor growth, thus having




Moment stability for nonlinear stochastic
growth kinetics of breast cancer stem cells
with time-delays1
3.1 Introduction
Breast cancer is a malignant disease with a heterogeneous distribution of cell types.
Despite aggressive clinical treatment including surgical resection, radiation, and chem-
otherapy, tumor recurrence is essentially universal. Therapeutic failure is due, in
part, to tumor cell heterogeneity, derived from both genetic and non-genetic sources,
which contributes to therapeutic resistance and tumor progression. Understanding
this heterogeneity is the key for the development of targeted cancer-preventative and
-therapeutic interventions. One of the currently prevailing models explaining intra-
tumoral heterogeneity is the CSC hypothesis [43, 44].
Cancer stem cells (CSCs) are defined as “a small subset of cancer cells" within a
cancer that can self-renew and replenish the heterogeneous lineage of cancer cells that
comprise the tumor. CSCs are often resistant to chemotherapeutic drugs, sharing sim-
ilar gene expression profiles and properties with normal stem cells such as formation
of spheres in culture, and may be responsible for tumor relapse and metastasis [45–
47]. A broad range of CSC frequency, often spanning multiple orders of magnitude,
has been observed in human solid tumors of various organ types [48–52]. According
142.
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to the CSC hypothesis [45], CSCs possess the ability to divide either symmetrically to
yield two identical immortal cancer stem cells; or asymmetrically, to simultaneously
self-renew and yield one mortal non-stem cancer cell with finite replicative potential
[49]. The proportion of CSCs has been speculated to be maintained through alterna-
tive use of symmetric and asymmetric division. However, it is largely unknown how
to control the switch between these two dividing modes. Mathematical modeling has
been utilized to study underlying mechanistic principles and to help design appro-
priate experiments for better understanding of complex dynamics and interactions of
tumor cell populations [53].
In [40], via the contraction fixed point theorem, the exponential stability has been
achieved in mean square of the stochastic neutral cellular neural network. Motivated
by [40], this chapter will investigate the moment stability of nonlinear stochastic
systems of breast cancer stem cells with time-delays based on comparison principle,
variation-of-constants formula and linear matrix inequality (LMI) techniques [42].
The rest of the chapter is organized in the following. In Section 3.2, we will
generalize the population dynamics with different cell types by a system of differential
equations, and introduce some notations. In Section 3.3, we sill study the stability
properties in mean square of the the stochastic system as developed in Section 3.2.
In Section 3.4, some numerical examples are provided to further demonstrate the
results. Finally, a brief conclusion is drawn.
3.2 Preliminaries
In [37], a mathematical model has been developed to explore the growth kinetics of
CSC population both in vitro and in vivo. Here we denote xi(t) the number of cells
at time t for cell types i, i = 0, 1, · · · , n− 1. Pi the probability that the cell type i is
divided into a pair of itself, Qi the probability that the cell type i is divided into a
pair of next cell lineage (cell type i + 1). Thus 1 − Pi − Qi denotes the probability
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that an asymmetric cell division takes place from cell type i to cell type i− 1. Here
vi is the synthesis rate which quantifies the speed for cell type i to divide in unit
time, di is the degradation rate, and w(t) = (w1(t), w2(t), · · · , wm(t))T ∈ Rm is a m-
dimensional Brownian motion defined on a complete probability space (Ω,F , P ). The
stochastic disturbance term, hk,ij (t, u1, u2) ∈ C(R×R+×R+)(k, i = 0, 1, · · · , n−1, j =
1, 2, · · · ,m), can be viewed as stochastic perturbations on the stem cells states and
delayed stem cells states. Here τ is a positive constant, Pi > 0, Qi > 0, νi > 0(i =
0, 1, 2, · · · , n− 2) are all decreasing functions of xn−1, which represents the negative
feedback from the terminally differentiated cell type n − 1. Based on the model
as developed in [37], a general population dynamics of different cell types can be
described by a system of stochastic ordinary differential equations,







h0,ij (t, xi(t), xi(t− τ))]dwj(t),
dx1(t) = {[1− P0(xn−1(t− τ)) +Q0(xn−1(t− τ))]ν0(xn−1(t− τ))x0(t)







h1,ij (t, xi(t), xi(t− τ))]dwj(t),
...
dxn−2(t) = {[1− Pn−3(xn−1(t− τ)) +Qn−3(xn−1(t− τ))]
× νn−3(xn−1(t− τ))xn−3(t)







hn−2,ij (t, xi(t), xi(t− τ))]dwj(t),
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hn−1,ij (t, xi(t), xi(t− τ))]dwj(t) (1.1)
Let (Ω,F , P ) be a complete probability space with a filtration {Ft}t≥0 satisfying
the usual conditions, i.e. it is right continuous and F0 contains all P -null sets. Let
CbF0([−τ, 0];R) be the family of all bounded, F0-measurable functions. We denote by




Since Pi, Qi and νi(i = 0, 1, 2, · · · , n − 2) are all decreasing functions of xn−1,
there exist some positive constants P i, Qi and νi such that
Pi(xn−1) ≤ P i, Qi(xn−1) ≤ Qi, νi(xn−1) ≤ νi for (i = 0, · · · , n− 2). (1.2)
To simplify, we can rewrite (1.1) as
dx = [F (t, x(t), x(t− τ))−Dx(t)]dt+∑mj=1Hj(t, x(t), x(t− τ))dwj(t) (1.3)
with the initial condition
x(s) = ϕ(s) ∈ C([−τ, 0];Rn), −τ ≤ s ≤ 0, (1.4)
where x(t) = (x0(t), x1(t), · · · , xn−1)T , D = diag(d0, d1, · · · , dn−1),


























































[P0 −Q0]ν0 0 · · ·
[1− P0 +Q0]ν0 [P1 −Q1]ν1 · · ·
... ... ...
0 0 · · ·
0 0 · · ·
· · · 0 0 0
· · · 0 0 0
... ... ... ...
· · · [1− Pn−3 +Qn−3]νn−3 [Pn−2 −Qn−2]νn−2 0
· · · 0 [1− Pn−2 +Qn−2]νn−2 0

.








We denote the mathematical expectation by E throughout the paper.
Definition 2.1. The system (1.3) with the initial condition is said to be the first
moment exponentially stable if there exist two positive constants µ and β such that
‖Ex(t;ϕ)‖2 ≤ µ‖ϕ‖2e−βt, t ≥ 0. (2.1)
Definition 2.2. The system (1.3) with the initial condition is said to be exponen-
tially stable in mean square if there exists a solution x of (1.3) and there exists a pair
of positive constants µ and β with
E‖x(t;ϕ)‖22 ≤ µE‖ϕ‖22e−βt, t ≥ 0. (2.2)
Definition 2.3. The system (1.3) with the initial condition is said to be globally





log(E‖x(t;ϕ)‖22) ≤ −ς. (2.3)
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Let C1,2(R+ × Rn;R+) denote the family of all nonnegative functions V (t, x)
on R+ × Rn which are continuously twice differentiable in x and once differen-
tiable in t. In order to study the mean square globally exponential stability, for
each V ∈ C1,2([−τ,∞) × R+;R+), define an operator LV , associated with the
uncertain stochastic neural networks with multiple mixed time-delays (1.3), from
(R+ × C[−τ ∗,∞);Rn) to R by
LV (t, x) = 12trace[(
m∑
j=1




Hj(t, x(t), x(t− τ)))]


























3.3 Stability of nonlinear stochastic systems of breast cancer
stem cells with time-delays
In this section, we will study the stability properties in mean square of the stochastic
nonlinear growth kinetics of breast cancer stem cells.
Throughout this paper, we always assume the following:












‖Hj(t, x(t), x(t− τ(t)))−Hj(t, y(t), y(t− τ(t)))‖2
≤ α(j)[‖x− y‖1 + ‖x(t− τ(t))− y(t− τ(t))‖2]
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and
‖C̃(0)j ‖3 + xT (t)C̃
(1)
j x(t) + xT (t− τ)C̃
(2)
j x(t− τ)
≤ HTj (t, x(t), x(t− τ))×Hj(t, x(t), x(t− τ))
≤ ‖C(0)j ‖3 + xT (t)C
(1)
j x(t) + xT (t− τ(t))C
(2)
j x(t− τ),
where T represents the transpose, j = 1, 2, · · · , · · · ,m, and

















j (t, xi(t), xi(t− τ))

.
Note from (1.3) and (1.4) that
x(t) = exp(−Dt){ϕ(0) +
∫ t
0 exp(Ds)[F (s, x(s), x(s− τ))]ds
+∑mj=1 ∫ t0 Hj(s, x(s), x(s− τ)) exp(Ds)dw(s)}.
(3.1)
From (A1) we have that F (·, ·, ·) and Hj(·, ·, ·) satisfy the Lipschitzian condition.
Then there is a unique solution of the system (1.1) through (t, ϕ).
3.1. The first moment stability.
Let x(t) be the solution of (1.1) and (1.2), we have from (3.1)
‖Ex(t;ϕ)‖2 = ‖ exp(−Dt){ϕ(0) +
∫ t
0 exp(Ds)[F (s, x(s), x(s− τ))]ds‖2. (3.2)
Now, we consider the following deterministic equation
dx = [−Dx(t) + F (t, x(t), x(t− τ(t)))]dt,
x(s) = ϕ(s) ∈ C([−τ, 0];Rn), −τ ≤ s ≤ 0.
(3.3)
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Let xϕ(t) be the solution of (3.3).
Theorem 3.1. Suppose
(A2) The solution of (3.3) is exponentially stable, i.e,. there exist two positive
constants κ and λ such that
‖xϕ(t)‖2 ≤ κ‖ϕ‖2e−λt, t ≥ 0.
Then the system (1.1) is first moment exponentially stable, i.e,.
‖Ex(t;ϕ)‖2 = ‖xϕ(t)‖2 ≤ κ‖ϕ‖2e−λt, t ≥ 0. (3.4)
Proof of Theorem 3.1. The result follows from (A2) and (3.2).
Remark 1. In fact, if the equilibrium of the system (3.3) is stable, or asymptotically
stable, then the equilibrium of the system (1.1) is also stable in first moment, or
asymptotically stable in first moment, respectively, i.e., the stability of the system
(3.3) implies the same stability of the system (1.1) in first moment.
For convenience, in the following discussions, we always assume that the system
(1.1) is first moment exponentially stable.
3.2. Mean square stability.
Now we study the stability in mean square of the system (1.1).
Since dwjds = 0, Edwj = 0 and E(dwj(s), dwk(s)) = δjkds(j, k = 1, 2, · · · ,m),
we have from the definitions of | · |1, ‖ · ‖2 , ‖ · ‖3 and (3.1) that
E|x(t)|21 = E| exp(−Dt){ϕ(0) +
∫ t
0






Hj(s, x(s), x(s− τ)) exp(Ds)dw(s)}|21
≤ E{2‖ϕ(0)‖22‖ exp(−Dt)‖23 + 2
∫ t
0







HTj (s, x(s), x(s− τ))
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×Hj(s, x(s), x(s− τ))]ds}










(‖C(0)j ‖3 + xT (s)C
(1)
j x(s)
+ xT (s− τ)C(2)j x(s− τ))]ds}














(‖C(0)j ‖3 + xT (s)C
(1)







× [C(0) + C(1)|x(s)|21 + C
(2)‖x(s− τ)‖22]ds}




× [C(0) + C(1)|x(s)|21 + C
(2)‖x(s− τ)‖22]ds, (3.5)
where λmin(D) represents the minimal eigenvalue of matrix D, λmax(C(0)j ),
λmax(C(1)j ) and λmax(C
(2)







1, 2, · · · ,m),
Φ = 2n2‖ϕ(0)‖22, C
(0) = n3∑mj=1 λmax(C(0)j ), C(2) = n3∑mj=1 λmax(C(2)j )
C




ed0(s−t) 0 0 · · · 0
0 ed1(s−t) 0 · · · 0
... ... ... ... ...
0 0 0 · · · edn−1(s−t)

and




Theorem 3.2. Let (A1) and (A2) be satisfied. Then
E|x(t)|21 ≤ u(t), t ≥ 0,
where u(t) is the solution of the comparison equation
u̇(t) = (−2λmin(D) + C
(1))u(t) + C(2)u(t− τ) + C(0), t ≥ 0,
u(s) ≥ Φ ≥ 0, s ∈ [−τ, 0].
(3.6)






2λmin(D)(s−t)[C(0) + C(1)|x(s)|21 + C
(2)‖x(s− τ)‖22]ds,
M(s) ≥ Φ, s ∈ [−τ, 0].
(3.7)
We have from (3.5) and (3.7)




+ C(2)‖x(s− τ)‖22]ds}+ C
(0) + C(1)E|x(t)|21 + C
(2)
E‖x(t− τ)‖22
≤ −2λmin(D)M(t) + C
(0) + C(1)M(t) + C(2)M(t− τ)
= (−2λmin(D) + C
(1))M(t) + C(2)M(t− τ) + C(0), t ≥ 0.
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From (3.7), let u(s) = M(s), s ∈ [−τ, 0]. From the comparison theorem of ordinary
differential equations, we get u(t) ≥M(t), t ≥ 0, u(s) ≥M(s), s ∈ [−τ, 0], and thus
E|x(t)|21 ≤M(t) ≤ u(t), t ≥ 0.
The proof is complete.
Theorem 3.3. If the assumptions of Theorem 3.2 are satisfied, and the equilibrium
of system (3.6) is stable, or asymptotically stable, then the equilibrium of system (1.1)
is also stable in mean square, or asymptotically stable in mean square, respectively,
i.e., the stability of system (3.6) implies the same stability of system (1.1) in mean
square.
3.3. Mean square instability.
Similar reasoning as in (3.5), we have from the definition of | · |1 and (3.1) that
E|x(t)|21 = E| exp(−Dt){ϕ(0) +
∫ t
0






Hj(s, x(s), x(s− τ(s))) exp(Ds)dw(s)}|21
= E{‖ exp(−Dt)‖23[ϕ(0) +
∫ t
0











HTj (s, x(s), x(s− τ))







(nλmin(C̃(0)j ) + nλmin(C̃
(1)
j )|x(s)|21


























e2λmax(D)(s−t)[Ĉ(0) + Ĉ(1)|x(s)|21 + Ĉ(2)‖x(s− τ)‖22]ds, (3.8)
where λmax(D) represents the maximal eigenvalue of D, λmin(C̃(1)j ) and λmin(C̃
(2)
j )
represent the minimal eigenvalues of C̃(1)j and C̃
(2)
j (j = 1, 2, · · · ,m),
Ĉ(0) = n3∑mj=1 λmin(C̃(0)j ), Ĉ(2) = n3∑mj=1 λmin(C̃(2)j ),
Ĉ(1) = n3∑mj=1 λmin(C̃(1)j )− 2n2[∑n−2i=0 νi(1 + 2P i + 2Qi)]2.
Theorem 3.4. Suppose
1) The assumptions (A1) and (A2) are satisfied;
2)
Ĉ(1) = n3∑mj=1 λmin(C̃(1)j )− 2n2[∑n−2i=0 νi(1 + 2P i + 2Qi)]2 > 0.
Then
E|x(t)|21 ≥ u(t), t ≥ 0,
where u(t) is the solution of the comparison equation
u̇(t) = (−2λmax(D) + Ĉ(1))u(t) + Ĉ(2)u(t− τ) + Ĉ(0), t ≥ 0,
u(s) ≥ 0, s ∈ [−τ, 0].
(3.9)




2λmax(D)(s−t)[Ĉ(0) + Ĉ(1)|x(s)|21 + Ĉ(2)‖x(s− τ)‖22]ds,
M(s) ≥ 0, s ∈ [−τ, 0].
(3.10)
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e2λmax(D)(s−t)[Ĉ(0) + Ĉ(1)|x(s)|21 + Ĉ(2)‖x(s− τ)‖22]ds
+ Ĉ(0) + Ĉ(1)E|x(t)|21 + Ĉ(2)E‖x(t− τ)‖22
≥ −2λmax(D)M(t) + Ĉ(0) + Ĉ(1)M(t) + Ĉ(2)M(t− τ)
= (−2λmax(D) + Ĉ(1))M(t) + Ĉ(2)M(t− τ) + Ĉ(0).
From (3.10), let u(s) = M(s), s ∈ [−τ, 0]. By the comparison theorem of ordinary
differential equations, we get u(t) ≤M(t), t ≥ 0, and thus
E|x(t)|21 ≥M(t) ≥ u(t), t ≥ 0.
The proof is complete.
Theorem 3.5. If the assumptions of Theorem 3.4 are satisfied, and the equilibrium
of system (3.10) is unbounded, then the equilibrium of system (1.1) is also unbounded
in mean square, i.e., the unboundedness of system (3.10) implies the same unbound-
edness of system (1.1) in mean square.
3.4. Mean square globally exponentially stable.
Theorem 3.6. Suppose (A1) and (A2) hold and assume that there exist matrices




HTj (t, x(t), x(t− τ))PHj(t, x(t), x(t− τ))]
≤ xT (t)M0x(t) +
m∑
j=1
xT (t− τ)Mjx(t− τ). (3.11)
Then system (1.1) is globally exponentially stable in mean square, if there exist positive
scalars µ > 0, ρ > 0 and positive definite matrices Γi > 0 (i = 1, 2, · · · ,m) such that
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the LMI holds:
−PD −DP + µQ+M0 0
+∑mj=1 ρΓj + 2∑n−2i=1 νi(1 + 2P i + 2Qi)P
0 ∑mj=1(Mj − ρΓj)− µQ

< 0.
Proof of Theorem 3.6. Let
V (t, x(t)) = xT (t)Px(t) + µ
∫ t
t−τ x
T (s)Qx(s)ds+∑mj=1 ρ ∫ tt−τ xT (s)Γjx(s)ds.
(3.12)
From Itô,s differential formula (see, e.g., [12]) we have along (1.3)




HTj (t, x(t), x(t− τ))PHj(t, x(t), x(t− τ))




− µxT (t− τ)Qx(t− τ)−
m∑
j=1
ρxT (t− τ)Γjx(t− τ)]. (3.13)
From (3.11) and (3.13), we have that




+ 2xT (t)PA(xn−1(t− τ))x(t)
+ xT (t− τ)[
m∑
j=1
(Mj − ρΓj)− µQ]x(t− τ)







νi(1 + 2P i + 2Qi)P ]x(t)
+ xT (t− τ)[
m∑
j=1
(Mj − ρΓj)− µQ]x(t− τ)
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= ξΠξT , (3.14)
where




−PD −DP + µQ+M0+ 0
∑m
j=1 ρΓj + 2
∑n−2
i=1 νi(1 + 2P i + 2Qi)P
0 ∑mj=1(Mj − ρΓj)− µQ

.
Let Ṽ (t, x(t)) = ektV (t, x(t)), where k is to be determined. It is easy to check that
V (t, x(t)) ≤ λmax(P )|x(t)|21 + µ
∫ t
t−τ x
T (s)Qx(s)ds+∑mj=1 ρ ∫ tt−τ xT (s)Γjx(s)ds.
Thus
LṼ (t, x(t)) = ekt[kV (t, x(t)) + LV (t, x(t)]











Choose k sufficiently small so that










xT (s)Γjx(s)ds] ≤ 0. (3.16)
From (3.15) and (3.16), we have
LṼ (t, x(t)) ≤ 0,
which implies that
EṼ (t, x(t)) ≤ EṼ (0, x(0)). (3.17)
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Therefore, we have
ektEV (t, x(t)) ≤ EV (0, x(0))











≤ [λmax(P ) + µτλmax(Q) +mτρλmax(Γ)] max−τ≤s≤0E|x(s)|
2
1, (3.18)
where λmax(Γ) = max{λmax(Γ1), λmax(Γ2), · · · , λmax(Γm)}. Also, it is easy to see that
EV (t, x(t)) ≥ λmin(P )|x(t)|21. (3.19)
From (3.18) and (3.19), it follows that




Thus system (1.1) is globally exponentially stable in mean square.
Remark 2. Note that [54] is a special case of system (1.1) and note that the Laplace
transform technique fails for system (1.1).
Remark 3. System (1.1) can be generalized to the general form
dx = [−(D +4D(t))x(t) + (B +4B(t))F (t, x(t), x(t− τ1(t)),










Hj(t, x(t), x(t− σj(t)))dw(t).
3.4 Examples
We consider the following special case of (1.1) with three types of of cells as in [37]
dx0 = {[
p0
1 + γ01(x2(t− τ))2
− q01 + γ02(x2(t− τ))2
] ν01 + β0(x2(t− τ))2
x0(t)
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− d0x0(t)}dt+ h0(x0(t− τ))dw0(t),
dx1 = {[1−
p0
1 + γ01(x2(t− τ))2
+ q01 + γ02(x2(t− τ))2
] ν01 + β0(x2(t− τ))2
x0(t)
+ [ p11 + γ11(x2(t− τ))2
+ q11 + γ12(x2(t− τ))2
] ν11 + β1(x2(t− τ))2
x1(t)
− d1x1(t)}dt+ h1(x1(t− τ))dw1(t),
dx2 = {[1−
p1
1 + γ11(x2(t− τ))2
+ q11 + γ12(x2(t− τ))2
] ν11 + β1(x2(t− τ))2
x1(t)
− d2x2(t)}dt+ h2(x2(t− τ))dw2(t). (4.1)
Here x0(t), x1(t), and x2(t) are the number of cancer stem cells (CSCs), progenitor
cells (PCs), and terminally differentiated cells (TDCs), respectively, at time t. The
time-delay τ is 0 for Figure (3.1) and 10 time units for Figure (3.2). There is only
one stochastic disturbance term, hi(xi(t− τ)), i = 0, 1, 2, for each cell type, and it is
an explicit function of only the cell type that it affects.
The figures show the solution of (4.1) implemented in MATLAB with initial con-
dition x(0) = (10, 200, 800)T . The parameters and stochastic terms used in each
figure are listed in Table (3.1). Figures (3.1) and (3.1) have the same parameters and
stochastic terms and differ only in the time delay. Due to the presence of a stochastic
term, each figure is the average of ten trials. The x-axis is time units, and the y-axis
is number of cells in a log-scale. The inset shows a zoomed-in portion of the graph.
In Figure (3.1)a, there is no noise term. The number of cells shoots up to about









The number of cells shoots up to about 104 and then levels off. Equilibrium is reached,


















The number of cells shoots up to about 104 and then levels off. Equilibrium is reached,
but there is small perturbation around the equilibrium position. In Figure (3.1)d,

















The number of cells shoots up and increases by orders of magnitude more than the
previous scenarios. There is large perturbation. Equilibrium is not reached, but the
total number of cells is between 106 and 1012.
In Figures (3.2)a, b, and c, the number of cells shoots up to about 106 and then
levels off. This is 100 times greater than in Figure (3.1). Equilibrium is reached,
but there are oscillations in the number of PCs and TDCs around the equilibrium
position. The noise term has a negligible effect in Figures (3.2)b and c. In Figure
(3.2)d, the number of cells shoots up and increases by orders of magnitude more than
the previous scenarios. There is small perturbation. Equilibrium is not reached, and
the number of cells grows unboundedly.
The parameters were chosen both from biological data from our collaborator’s lab
[37] and from requiring that equilibrium is reached. From experiments with tumor
cells we know that the degradation rate is the greatest for TDCs, then PCs, and then




Figure 3.1: Solution of (4.1). Parameters and noise functions are listed in Table (3.1).
τ = 0. These are the average of ten trials.
collaborator’s lab. Additionally, the probabilities, p0, q0, p1, and q1, and degradation
rates, d0, d1, and d2, are between 0 and 1 by definition. With these restrictions, the
parameters were then chosen through guess and check until equilibrium was reached.
3.5 Conclusion
Breast cancer is a malignant disease with a heterogeneous distribution of cell types.
Mathematical modeling has been utilized to study underlying mechanistic principles
and to help design appropriate experiments for better understanding of complex dy-
namics and interactions of tumor cell populations. In this chapter, we have studied
the moment stability of nonlinear stochastic systems of breast cancer stem cells with




Figure 3.2: Solution of (4.1). Parameters and noise functions are listed in Table (3.1).
τ = 10. These are the average of ten trials.
the comparison principle, the moment stability theorems have been established for
the systems with the stability properties for the comparative systems. By apply-
ing the linear matrix inequality (LMI) technique, we also obtain a criteria for the
exponential stability in mean square of the nonlinear stochastic systems. Some nu-
merical examples are performed to further validate the results [42]. As discussed in
[37], the results developed in this chapter will help to further reveal the underlying
mechanisms to regulate and control the dynamics of cancer tumor growth. Hence
the outcome of this study may potentially lead to design novel therapeutic strategies
for treating cancer development. We plan next to explore the stochastic dynamics
of breast cancer cells with inherent noise perturbation on the variations of different
parameters.
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p0 0.5 0.5 0.5 0.5
p1 0.001 0.001 0.001 0.001
q0 0.2 0.2 0.2 0.2
q1 0.9 0.9 0.9 0.9
ν0 10 10 10 10
ν1 10 10 10 10
γ01 7× 10−9 7× 10−9 7× 10−9 7× 10−9
γ11 2× 102 2× 102 2× 102 2× 102
γ02 4× 10−10 4× 10−10 4× 10−10 4× 10−10
γ12 8× 10−18 8× 10−18 8× 10−18 8× 10−18
β0 3× 10−8 3× 10−8 3× 10−8 3× 10−8
β1 2× 10−7 2× 10−7 2× 10−7 2× 10−7
d0 0.001 0.001 0.001 0.001
d1 0.08 0.08 0.08 0.08




























h0 - - 300 3
h1 - - 5000 10
h3 - - 6000 22
g0 - - 10 10
g1 - - 10 10
g3 - - 20 20
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Chapter 4
Mathematical Modeling of HER2 Signaling
Pathway in Breast Cancer Cells
4.1 Introduction
The cancer stem cell hypothesis states that there is a small subset of tumor cells, called
cancer stem cells (CSCs), that are responsible for the proliferation and resistance to
therapy of tumors. CSCs have the ability to self-renew and differentiate to form the
nontumorigenic cells found in tumors [55]. Studies have shown that over-expression of
human epidermal growth factor receptor 2 (HER2) plays a role in regulation of CSC
population in breast cancer. As a result, current cancer therapy includes drugs that
block HER2 for patients with HER2+ breast cancer. However, patients can develop
anti-HER2 drug resistance [56]. Downstream of HER2 is nuclear factor κ B (NFκB).
The aberrant regulation of NFκB leads to cancer growth through proliferation of
CSCs and inhibition of CSC apoptosis. This makes it a promising target for cancer
therapy, especially for those who have developed resistance to anti-HER2 treatment
[57–59]. Through in vitro experiments, our lab has discovered that interleukin-1 (IL1),
which is downstream of HER2, is responsible for NFκB activation, thus making it
a potential target for cancer treatment. We develop a mathematical model of this
signaling pathway to better understand its dynamics and to help guide breast cancer
treatment.
Several studies have shown that HER2 plays a role in regulation of CSCs in
breast cancer. For example, Korkaya, et al. show that over-expression of HER2 in
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cell populations increases both the CSC population and the tumorigenicty within the
population. Current available treatments for HER2+ breast cancer include drugs
that inhibit HER2. Although this treatment has been successful for many patients, a
fraction of patients develop resistance to these drugs [56]. This has led to the study
of the HER2 signaling pathway in order to find alternative targets for cancer therapy.
One such protein of interest downstream of HER2 is NFκB since aberrant regulation
of this protein is found in many types of cancers, including breast cancer, and since it
is shown to cause the dangerous features of cancer [59]. Moreover, NFκB activation
is shown to render HER2+ cells drug resistant. Study of this pathway has shown the
following downstream: HER2, AKT, IKK, NFκB [57, 58]. This suggests inhibition
of NFκB alongside anti-HER2 therapy in order to combat anti-HER2 resistance of
breast cancer cells. Merkhofer et al. propose this to be done by targeting IKK [57].
In vitro experiments in our lab show that HER2 is able to activate NFκB through
IL1. We propose the following downstream: HER2, ERK, IL1, IKK, NFκB.
In this chapter, we develop a novel mathematical model of the HER2 signaling
pathway. A new feature of the model is the simplified downstream dynamics of the
IκB-NFκB dissociation and association loop. This pathway was first modeled by
Hoffmann, et al. [60] and has been studied by others since [61–63]. Previous studies
have developed complicated models for this interaction by accounting for various
reactions and species. Another new feature of the model is the incorporation of IL1
as an intermediary between HER2 and NFκB, which is a new relationship discovered
by our lab. The simplified model fits the experimental data, while the presence of
IL1 explains some observed phenomena. We use the model to make predictions for
breast cancer treatment scenarios. We also perform global sensitivity analysis on
NFκB concentration with respect to the parameters to reduce the dimension of the
parameter space and identify key reactions in the model [64].
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4.2 Model
Through studying the literature and running simulations, we propose the following
model. HER2 binds to the cell membrane and signals to activate ERK and AKT.
ERK activates IL1. AKT and IL1 activate IKK. The pathway from HER2 to IKK
through AKT is well known. Our experiments and modeling suggest the new path-
way from HER2 to IKK through IL1. IKK phosphorylates the IκB-NFκB complex,
causing it to dissociate into p-IκB and p-NFκB. p-IκB then degrades. p-NFκB gives
positive feedback to IL1. p-NFκB goes to the nucleus and synthesizes IκB. The free
nuclear p-NFκB causes cancer growth and is hence the focus of our study. p-NFκB
and IκB then associate to form the complex IκB-NFκB [60, 61, 65]. This is schemat-
ically represented in Figure 4.1. The HER2 signaling pathway is far more complex
than the one shown. However, this model is a simplified representation of the sig-
naling pathway, and it captures the key components needed for our study. There
are two novel aspects of this model. One is the incorporation of IL1 in the upstream
dynamics. This is important because studying IL1’s role in NFκB can provide insight
into regulating NFκB for treating patients with HER2+ breast cancer. The other
is the simplified dynamics between IKK, IκB, and NFκB. A mathematical model of
this was proposed in 2002 by Hoffmann, et al. which considered the interactions in
detail [60]. Since then, others have used this model. We draw upon two simplified
versions of this model. Sung, et al. considered a time delay for free NFκB’s synthesis
of IκB [62]. And Zambrano, et al. omitted certain complexes and cytoplasm to nu-
cleus transport [63]. Combining these two approaches with further simplification, we
arrive at the model in Figure 4.1. This model simplifies the interaction between IKK,
IκB, and NFκB, while still capturing the dynamics, as shown by the model’s ability
to reproduce our experimental data. Moreover, some phenomena are explained by
IL1’s presence in this pathway and its positive feedback from NFκB.
The equations used to represent the concentrations of each protein are based on
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Figure 4.1: Schematic representation of the HER2 signaling pathway.
mass action kinetics, which states that the rate of a reaction is proportional to the
concentration of the species involved in the reaction. The dynamics considered are ac-
tivation, inhibition, dissociation, association, and degradation. There is an equation
for each protein in the model that represents the rate of change of its concentration,
resulting in the system of delay ordinary differential equations in (4.1) - (4.8), where
the variables and parameters are listed in Tables 4.1 and 4.2, respectively.
dx2
dt
= k1x1 − k2x3x2 − d1x2 (4.1)
dx3
dt
= k3x1 − d2x3 (4.2)
dx4
dt
= k4x2 + k5x8 − d3x4 (4.3)
dx5
dt
= k6x3 + k7x4 − d4x5 (4.4)
dx6
dt
= −k8x5x6 + k9x9x8 (4.5)
dx7
dt
= k8x5x6 − d5x7 (4.6)
dx8
dt
= k8x5x6 − k9x9x8 (4.7)
dx9
dt




= x6 + x7 + x9 (4.9)
Table 4.1: Variables in the HER2 signaling pathway model.
Variable Protein Variable Protein
x1 [HER2] x6 [IκB-NFκB]
x2 [ERK] x7 [p-IκB]
x3 [AKT] x8 [p-NFκB]
x4 [IL1] x9 [IκB]
x5 [IKK] x10 [IκB]total
Table 4.2: Parameters in the HER2 signaling pathway model.
Parameter Description
k1 [ERK] activation by [HER2]
k2 [ERK] inhibition by [AKT]
k3 [AKT] activation by [HER2]
k4 [IL1] activation by [ERK]
k5 [IL1] activation by [p-NFκB]
k6 [IKK] activation by [AKT]
k7 [IKK] activation by [IL1]
k8 [IκB-NFκB] phosphorylation by [IKK]
k9 [IκB-NFκB] association from [IκB] and [p-NFκB]







The concentrations of these proteins are measured in a cell culture at equilibrium at
time zero. The western blots, quantified data, and model fits are in Figure 4.2. Each
plot shows the relative change in NFκB concentration versus time. The black symbol
is the quantified western blot data, and the red line is the fitted model. In experiment
a, HER2 is over-expressed. Then at time zero, HER2 is blocked, which causes NFκB
to initially decrease. NFκB then increases and continues to oscillate damply near the
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baseline level due to the delayed feedback loop with IκB. Experiment b is the same
as a, but with the data collected less frequently and for a long time, as a result of
which we do not see oscillations. Here NFκB remains near the baseline level for about
eight hours before it gradually decreases. In experiment c, HER2 is over-expressed.
Then IL1 is added at time zero, which causes NFκB to increase significantly and
then decrease. There is no HER2 in the cell culture in experiment d. At time zero
IL1 is added, which causes NFκB to increase sharply and then gradually decrease.
In experiment e, HER2 is over-expressed. Then IL1 is blocked at time zero, which
causes NFκB to initially decrease sharply. It then oscillates damply. There is no
HER2 in the cell culture in experiment f. At time zero IL1 is blocked, which causes
NFκB to gradually decrease and then increase.
These results confirm that NFκB is downstream to HER2 since when HER2 is
blocked, NFκB decreases. Inhibiting HER2 alone causes a gradual decay in NFκB
after remaining near the baseline level for several hours. Additionally, these results
show that IL1 activates NFκB, even in the absence of HER2, since with and without
HER2, addition of IL1 increases the NFκB concentration. Likewise, blocking IL1,
with and without HER2, causes NFκB to decrease. Hence, since IL1 is upstream of
NFκB, it is a potential target for NFκB regulation as an effective strategy for tumor
suppression in breast cancer therapy.
As seen in Figures 4.2 (a) and (b), after blocking HER2, NFκB concentration does
not immediately decrease. For the short time data, there are damped oscillations
around the baseline level for the first three hours. For the long time data, it remains
near the baseline level for the first eight hours after which is gradually decreases.
Therefore there is something upstream to NFκB that sustains it at a high level. Our
model suggests IL1 is the intermediary in this pathway that sustains high NFκB
concentration. And unlike with ERK or AKT, it is the positive feedback from NFκB
to IL1 that creates this loop. In light of this, we predict the following scenario. As in
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(a) Over-expression of HER2. Reach
equilibrium. Block HER2.
(b) Over-expression of HER2. Reach
equilibrium. Block HER2.
(c) Over-expression of HER2. Reach
equilibrium. Add IL1.
(d) No HER2. Reach equilibrium. Add
IL1.
(e) Over-expression of HER2. Reach
equilibrium. Block IL1.
(f) No HER2. Reach equilibrium. Block
IL1.
Figure 4.2: Western blot data, quantified data, and model fits of experiments.
Figure 4.2 (a), we over-express HER2 and let the system reach equilibrium. Then at
time zero, we block the positive feedback from NFκB to IL1, parameter k5, in addition
to HER2. The result is in Figure 4.3. We see that there is a sharp decrease in NFκB
concentration, which shows that IL1 is what sustains high NFκB concentration in
the absence of HER2.




The model system of equations is solved numerically in MATLAB. The protein con-
centrations are normalized between 0 and 1. Over-expression of HER2 is simulated
with a constant concentration of 1. The initial values of proteins are determined
though optimization. The simulation is run until the system reaches equilibrium.
Then at time zero the different experiments are simulated. The blot data is quan-
tified. The data is then converted to relative change by dividing all values by the
initial value. The model system of equations is first solved, and then converted to
relative change.
All parameters and initial conditions are found using MATLAB’s nonlinear con-
strained minimizer fmincon. Given a set of parameters and initial conditions, the
system of delay ordinary differential equations is solved, after which the error sum
of squares is calculated between the model output and the given data. This function
is minimized in fmincon over the set of parameters and initial conditions. The ex-
periments each have different sets of parameters which are found from minimization
of the error sum of squares with their respective data. The range to search for the
parameters and initial conditions is [0, 1]. The finite difference relative step size of
fmincon is reduced to ensure proper exploration of the parameter space. The time
delay is fixed between 15− 60 minutes as a biologically reasonable range.
4.5 Sensitivity Analysis
Sensitivity analysis is performed on the model to quantify how the model output
varies with the parameter input. We perform global sensitivity analysis instead of
local. Local sensitivity analysis only shows how model output varies with individual
parameters. And it shows this variation at a point. Global sensitivity analysis, on the
other hand, accounts for parameter interaction and shows how model output varies
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with all parameters. And it shows this variation over the whole parameter space [66].
We use the variance based global sensitivity analysis method from Saltelli, et al.
This method is model independent, has the capacity to capture the full range of vari-
ation of each parameter, and can indicate interaction effects among parameters. It is
also computationally reasonable for our model. The variance based method quantifies
how influential a parameter is on the model output. This gives us further understand-
ing of the model dynamics by knowing which reactions are most influential. It also
aids in the parameter fitting. Parameters that are influential can be prioritized, and
parameters that are noninfluential can be fixed to a nominal value, thus reducing the
dimension of the parameter space [66]. This may improve the parameter estimation
since an optimizer’s efficacy decreases with increasing number of unknowns.
Let k be the number of parameters, Xi be the ith parameter, and
Y = f(X1, X2, . . . , Xk)
be the model output. For i = 1, 2, . . . , k, we compute the first-order sensitivity
indices,
Si =
V [E(Y | Xi)]
V (Y ) , (4.10)
and the total-effects sensitivity indices,
ST i = 1−
V [E(Y |X∼i)]
V (Y ) , (4.11)
where E(· | ·) and V [·] are the conditional expectation and variance, respectively,
and X∼i indicates all parameters except Xi. Si measures how influential Xi is. A
large Si means that Xi is influential. However, a small Si does not mean that Xi
is noninfluential. That is because Xi may be influential by interacting with other
parameters. That is why we calculate ST i, which measures how influential Xi is while
interacting with other parameters. A large ST i means that Xi is influential, and a
small ST i means that Xi is noninfluential [66].
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Si and ST i are efficiently calculated by a Monte Carlo simulation as described
in Saltelli, et al. [66, 67]. The k = 15 parameters are sampled N = 2000 times
in two sets. All parameters are uniformly distributed in [0, 1]. The samples are
quasi-randomly generated by Sobol’s LPτ sequence because this sequence is more
uniformly distributed than pseudo-random samples generated by a computer [68].
This algorithm requires N(k + 2) model evaluations.
The result of the sensitivity analysis on NFκB concentration is given in Figure 4.4
(a). The sensitivity indices as a percentage are plotted versus each parameter in the
model (4.1) - (4.8). We run the simulation by over-expressing HER2 and letting the
system reach equilibrium. Then the first-order and total-effects sensitivity indices
(4.10) and (4.11) are calculated at an equilibrium time point (800 minutes). We
see that out of the 15 parameters, only five have a considerable influence on NFκB
concentration. Parameter number 8 is the most influential, which is an obvious result
because it is the IκB-NFκB dissociation rate. What is not obvious is that parameter
number 5, which is the activation rate for the positive feedback from NFκB to IL1,
is not influential. Knowing the most influential parameters allows us to reduce the
dimension of the parameter space in studying the dynamics of NFκB. In estimating
parameters to fit data, we let the optimizer find the value of the five parameters, while
setting the other ten to a nominal value. The identification of key parameters also
aids in guiding what reactions to focus on in future lab and numerical experiments.
Since over-expression of HER2 is found in breast cancer patients, chemotherapy
protocol includes drugs that block HER2. The problem is that in some patients, the
tumor relapses despite receiving these drugs. NFκB being both downstream to HER2
and able to cause cancer is of interest in this scenario. Therefore, in Figure 4.4 (b), we
again compute the sensitivity indices (4.10) and (4.11) on NFκB concentration in the
model (4.1) - (4.8), but for the simulation over-expression of HER2, reach equilibrium,
and then block HER2 at time 0. This is again calculated at an equilibrium value (800
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(a) Over-expression of HER2. Reach
equilibrium.
(b) Over-expression of HER2. Reach
equilibrium. Block HER2.
Figure 4.4: Sensitivity analysis of the model (4.1) - (4.8).
minutes after time 0). In this scenario versus the previous one, we observe is that the
total-effects sensitivity index ST i greatly increases for parameters 5, 7, and 13 (circled
in the figure). These parameters are the positive feedback from NFκB to IL1, the
activation of IKK by IL1, and the degradation of IL1, respectively. This shows that
in the absence of HER2, IL1 becomes increasingly important for NFκB regulation.
4.6 Conclusion
Over-expression of HER2 is found in breast cancer patients. The HER2 signaling
pathway is critical in regulating CSC population in breast cancer tumors. Thus,
breast cancer therapy includes drugs that block HER2. However many patients de-
velop a resistance to these drugs, and their tumor relapses. Downstream of HER2
is NFκB, whose aberrant regulation can cause cancer, making it a promising target
for breast cancer therapy. In this study we discovered IL1’s presence in this path-
way. We developed a novel mathematical model of the HER2 signaling pathway that
simplifies some of the reactions and accounts for the dynamics involving IL1. This
simplified model is sufficient to reproduce experimental findings, and the presence of
IL1 explains certain experimental observations. We made a prediction for a specific
treatment scenario. And we performed global sensitivity analysis on the model to re-
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veal the key parameters influencing NFκB concentration [64]. Our proposed pathway,
model prediction, and sensitivity analysis suggest that IL1 is a crucial component in
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